Strabismus

H7_STRABISMUS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints H7_PARASTRAB H7_STRABOTH	14468
6. Filter based on genotype QC (FinnGen only)	13007

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF2

NAME	H7_STRABISMUS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	H7_PARASTRAB\|H7_STRABOTH
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Strabismus based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	13007	8105	4902
Unadjusted period prevalence (%)	2.64	2.88	2.25
Median age at first event (years)	34.09	28.82	42.81

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
13481: Matched controls
134421

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

CE2W4

NOMESCO Finland

Eye movement mapping

46.9

308.9

181

H50.8

ICD-10 Finland

Other specified strabismus

246.7

307.7

243

H49.1

ICD-10 Finland

Fourth [trochlear] nerve palsy

1906.0

307.7

855

3507

FHL

Retroposition and resection

1373.1

307.7

399

3782B

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Intermittent heterotropia[STRABISMUS DIVERGENS INTERMITTENS]

+∞

307.7

315

3503

FHL

Single muscle retroposition

8529.5

307.7

815

CEC10

NOMESCO Finland

Recession and resection of extraocular muscle

2023.5

307.7

1179

H50.31

ICD-10 Finland

Intermittent exotropia

1004.8

307.7

1599

H50.30

ICD-10 Finland

Intermittent esotropy

719.8

307.7

814

H50.2

ICD-10 Finland

Vertical strabismus

407.4

307.7

1158

XCW99

NOMESCO Finland

Other investigative procedure of eye

3.4

307.7

2133

6972

H50.0

ICD-10 Finland

Convergent concomitant strabismus

1416.2

307.7

1285

CEC00

NOMESCO Finland

Recession of extraocular muscle

3479.3

307.7

684

H53.0

ICD-10 Finland

Amblyopia ex anopsia

12.7

307.7

477

388

H50.52

ICD-10 Finland

Exophoria

220.1

307.7

2027

108

H50.9

ICD-10 Finland

Strabismus, unspecified

81.6

307.7

382

H50.1

ICD-10 Finland

Divergent concomitant strabismus

1022.9

307.7

1298

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

3530.8

307.7

1325

37303

ICD-8 Finland

Strabismus, Heterophoria (exophoria, esophroria, hypophoria)

+∞

307.7

736

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.5

307.7

3153

14535

37300

ICD-8 Finland

Strabismus, Concomitans convergens

+∞

307.7

1074

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

3606.0

307.7

707

H50.51

ICD-10 Finland

Esophoria

165.8

307.7

634

37301

ICD-8 Finland

Strabismus, Concomitans divergens

+∞

307.7

1668

H53.2

ICD-10 Finland

Diplopia

19.7

307.7

2190

1310

3781B

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Divergent concomitant strabismus[STRABISMUS DIVERGENS ALTERNANS]

+∞

299.8

287

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.8

284.3

1624

6314

37720

ICD-8 Finland

Other diseases of retina and optic nerve, Amblyopia

69.7

279.1

152

H50.59

ICD-10 Finland

Heterophor UNS

84.8

270.0

143

3781A

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Divergent concomitant strabismus[STRABISMUS CONCOMITANS DIVERGENS]

+∞

258.9

248

3780A

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Convergent concomitant strabismus[STRABISMUS CONCOMITANS CONVERGENS]

+∞

244.2

234

CEC30

NOMESCO Finland

Resection of extraocular muscle

2284.8

242.9

235

XCK00

NOMESCO Finland

Perimetry

3.2

239.5

1048

3503

F95

ICPC

Strabismus

41.2

223.5

135

H50.50

ICD-10 Finland

Alternating hyperphoria

46.7

221.6

130

H52.0

ICD-10 Finland

Hypermetropia

4.5

217.8

545

1242

3505

FHL

Single muscle resection

+∞

213.9

205

AA1AD

NOMESCO Finland

CT of head and brain

1.9

211.6

3752

22893

CEC60

NOMESCO Finland

Transposition of extraocular muscle with adjustable suture

+∞

210.7

202

3780B

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Convergent concomitant strabismus[STRABISMUS CONVERGENS ALTERNANS]

+∞

196.1

188

3784B

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Heterophoria[EXOPHORIA]

+∞

188.8

181

37302

ICD-8 Finland

Strabismus, Concomitans sursum sive deorsum vergens

+∞

186.7

179

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.3

185.2

1563

7229

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.5

174.4

621

1821

H51.1

ICD-10 Finland

Convergence insufficiency and excess

13.3

173.3

164

124

CEW99

NOMESCO Finland

Other operation on extraocular muscle

1760.5

171.9

167

3504

FHL

Retroposition of two muscles

1527.2

152.1

148

H06.2*E05.9

ICD-10 Finland

Dysthyroid exophthalmos

9.4

151.8

182

196

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

144.9

5280

38407

H50.4

ICD-10 Finland

Other and unspecified heterotropia

468.1

140.4

140

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

6.8

127.3

201

300

37001

ICD-8 Finland

Refractive errors, Hypermetropia. Hyperopia

46.4

125.7

H53.3

ICD-10 Finland

Other disorders of binocular vision

8.7

124.9

159

185

3783A

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Other and unspecified heterotropia

+∞

124.0

119

H53.1

ICD-10 Finland

Subjective visual disturbances

2.2

123.9

1084

5053

H52.3

ICD-10 Finland

Anisometropia and aniseikonia

5.7

118.9

224

399

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.1

117.1

1243

6244

WX140

NOMESCO Finland

Parabulbar anesthesy

2.7

113.9

630

2377

CA1BG

NOMESCO Finland

Eye and orbita MRI examination with high intensity magnet

10.1

110.7

125

124

H55

ICD-10 Finland

Nystagmus and other irregular eye movements

9.4

110.2

132

142

H50.6

ICD-10 Finland

Mechanical strabismus

+∞

107.3

103

H52.2

ICD-10 Finland

Astigmatism

3.4

100.5

377

1140

TAB00

NOMESCO Finland

Lumbar puncture

2.4

97.9

686

2898

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.0

96.3

1162

6098

3785A

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Paralytic strabismus

+∞

94.8

37304

ICD-8 Finland

Strabismus, paralyticus. Paresis nervorum III, IV, VI

+∞

90.6

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.5

90.3

3683

26781

R51.80

ICD-10 Finland

Headache

1.6

88.4

2262

14786

CEC20

NOMESCO Finland

Recession and advancement of extraocular muscle

+∞

85.4

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

5.2

82.1

168

323

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.1

79.4

807

3972

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.8

77.5

1418

8458

R42

ICD-10 Finland

Dizziness and giddiness

1.5

77.5

2745

19273

G80.1

ICD-10 Finland

Spastic diplegic cerebral palsy

17.5

77.1

G70.0

ICD-10 Finland

Myasthenia gravis

8.1

75.5

101

125

CS494

NOMESCO Finland

Other visual field testing

2.9

74.0

353

1229

N07AA02

ATC

pyridostigmine; systemic

6.8

74.0

116

172

XA800

NOMESCO Finland

Neuropsychological investigation

2.2

72.5

620

2849

H52.1

ICD-10 Finland

Myopia

2.2

71.8

609

2789

H02.4

ICD-10 Finland

Ptosis of eyelid

2.7

71.1

389

1457

H51.8

ICD-10 Finland

Other specified disorders of binocular movement

23.2

70.4

CEC90

NOMESCO Finland

Total transposition of extraocular muscle or muscles

+∞

69.8

CEC50

NOMESCO Finland

Advancement of extraocular muscle

+∞

69.8

H49.9

ICD-10 Finland

Paralytic strabismus, unspecified

+∞

67.7

N03AX12

ATC

[U] gabapentin; oral

1.6

67.5

1835

12100

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

66.9

1479

9264

ZXA10

NOMESCO Finland

Bilateral

1.5

65.8

2067

14078

H50.3

ICD-10 Finland

Intermittent heterotropia

+∞

64.6

37309

ICD-8 Finland

Strabismus, Unspecified

+∞

63.5

H50

ICD-10 Finland

Other strabismus

217.1

63.1

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

62.9

1390

8699

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.4

62.6

5353

43761

N03AX09

ATC

lamotrigine; oral

2.0

60.8

704

3625

37929

ICD-8 Finland

Blindness, one eye, specifically defined

26.3

60.6

F79.0

ICD-10 Finland

Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour

6.8

60.6

138

108

Kela drug reimbursment

Myasthenia gravis

8.8

60.5

H47.2

ICD-10 Finland

Optic atrophy

6.4

60.1

100

158

P85

ICPC

Mental retardation

6.7

59.8

143

Z3231

NOMESCO Finland

Registered nurse

1.4

59.7

3207

24229

N03AG01

ATC

valproic acid; systemic, rectal

1.9

59.7

757

4021

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.0

59.4

665

3385

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

59.0

884

4954

N03AX16

ATC

[U] pregabalin

1.5

59.0

2527

18308

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

58.6

2986

22336

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

4.4

58.5

146

332

F70.0

ICD-10 Finland

Mild mental retardation, With the statement of no, or minimal, impairment of behaviour

5.7

57.7

107

188

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.8

57.5

289

1036

Z3229

NOMESCO Finland

Other healthcare associate professional

1.8

56.3

962

5605

CA1CM

NOMESCO Finland

Eye and orbita extensive MRI examination with 3 Tesla magnet

9.4

55.7

G35

ICD-10 Finland

Multiple sclerosis

3.0

55.4

253

860

N06AX11

ATC

mirtazapine; oral

1.4

55.4

4042

32063

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

54.1

2876

21629

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

54.0

3173

24277

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

2.3

53.4

400

1737

G91.1

ICD-10 Finland

Obstructive hydrocephalus

6.8

53.0

123

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

53.0

3933

31232

H05.2

ICD-10 Finland

Exophthalmic conditions

8.5

53.0

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

52.7

3089

23608

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

52.1

1376

8977

3680A

ICD-9 Finland

Visual disturbances, Amblyopia ex anopsia

83.1

51.8

XCK10

NOMESCO Finland

Photography of fundus of eye

1.7

51.1

986

5939

ZXA05

NOMESCO Finland

Left side

1.4

51.1

2494

18449

H50.39

ICD-10 Finland

Intermittent heterotropia

176.8

50.9

N05AH04

ATC

quetiapine; oral

1.5

50.8

2200

15918

SPAT1301

SPAT

No procedures

1.4

50.3

3613

28501

3782A

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Intermittent heterotropia[STRABISMUS CONVERGENS INTERMITTENS]

+∞

50.0

F05

ICPC

Visual disturbance other

2.2

49.6

439

2045

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.8

49.5

827

4783

F83

ICD-10 Finland

Mixed specific developmental disorders

3.8

49.5

151

399

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.7

49.1

928

5558

ZXA00

NOMESCO Finland

Right side

1.4

48.6

2671

20150

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

48.1

2460

18324

R62.0

ICD-10 Finland

Delayed milestone

3.9

48.0

142

367

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.8

47.6

722

4058

N06AX16

ATC

venlafaxine; oral

1.5

46.9

1742

12216

3508

FHL

Transposition or anteposition

+∞

46.8

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.6

46.8

1190

7685

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.1

46.6

447

2147

H26.4

ICD-10 Finland

After-cataract

1.7

46.0

964

5930

H06.2

ICD-10 Finland

Dysthyroid exophthalmos

9.6

45.4

N06AX21

ATC

duloxetine; oral

1.5

44.8

1405

9506

H04.10

ICD-10 Finland

Dry eye syndrome

1.5

44.7

1392

9404

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

44.6

2657

20274

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

44.5

2386

17889

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

2.2

43.6

364

1656

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

43.5

1719

12192

N02BE01

ATC

paracetamol; systemic, rectal

1.4

42.9

11221

104976

G51.0

ICD-10 Finland

Bell palsy

2.3

42.8

321

1396

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

3.1

42.6

177

571

H57.1

ICD-10 Finland

Ocular pain

1.9

42.5

522

2741

R06.0

ICD-10 Finland

Dyspnoea

1.4

42.1

2954

23100

N03AF02

ATC

oxcarbazepine; oral

2.1

41.9

415

2018

SPAT1263

SPAT

Sampling

1.3

41.5

4966

41818

N05CF01

ATC

zopiclone; oral

1.3

40.8

3336

26668

3510

FHL

Cardiac surgery on three or more muscles

+∞

40.6

H49.8

ICD-10 Finland

Other paralytic strabismus

+∞

40.6

G80.2

ICD-10 Finland

Spastic hemiplegic cerebral palsy

9.4

40.5

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

3.2

40.2

162

513

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.0

40.1

466

2400

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

3.2

40.1

162

514

TCG00

NOMESCO Finland

Protection of cornea and sclera with soft lens

6.2

40.0

110

37002

ICD-8 Finland

Refractive errors, Myopia

12.6

39.9

G04BD12

ATC

mirabegron; oral

1.5

39.7

1170

7801

H53.4

ICD-10 Finland

Visual field defects

2.5

39.6

243

965

H27.0

ICD-10 Finland

Aphakia

7.0

39.6

3519

FHL

Other measure in this category

+∞

39.6

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

39.2

945

6015

N03AX14

ATC

levetiracetam; systemic

2.2

39.2

350

1636

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.4

39.0

283

1214

H02AB06

ATC

prednisolone; systemic

1.3

38.8

5380

46032

SPAT1229

SPAT

Assessment of need for aid

1.7

38.8

738

4422

F79.9

ICD-10 Finland

Unspecified mental retardation, without mention of impairment of behaviour

11.1

38.7

XCD10

NOMESCO Finland

Electrophysiological examination of eye

2.4

38.5

259

1073

G80.9

ICD-10 Finland

Cerebral palsy, unspecified

11.4

38.5

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.1

38.5

391

1920

SPAT1312

SPAT

General health counselling

1.3

38.3

3846

31572

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

3.2

38.2

151

473

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

3.4

38.1

139

414

SPAT1310

SPAT

Counselling related to known health issue

1.3

38.1

3639

29667

M79.6

ICD-10 Finland

Pain in limb

1.3

38.1

5237

44728

S06.0

ICD-10 Finland

Concussion

1.5

38.1

1291

8865

A28

ICPC

Limited function/disability NOS

1.4

38.1

1689

12219

A02BC02

ATC

pantoprazole; systemic

1.3

38.0

7911

70995

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

37.8

9141

83517

N03AX11

ATC

topiramate; oral

2.2

37.8

329

1523

Z2445

NOMESCO Finland

Psychologist

1.8

37.6

554

3083

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.9

37.6

470

2483

M03BX01

ATC

baclofen; systemic

2.5

37.4

237

955

N02AX02

ATC

tramadol; systemic, rectal

1.3

37.4

4645

39150

A06AD11

ATC

lactulose; oral

1.5

37.4

1398

9789

H54.5

ICD-10 Finland

Severe visual impairment, monocular

4.3

37.3

220

183

Kela drug reimbursment

Lamotrigin and topiramate

3.1

37.3

152

485

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.4

37.2

1652

11950

109

Kela drug reimbursment

Multiple sclerosis

2.9

37.0

175

608

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

37.0

1719

12535

UKC02

NOMESCO Finland

Cystoscopy

1.5

36.9

1478

10489

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

2.5

36.8

225

892

G47.3

ICD-10 Finland

Sleep apnoea

1.4

36.5

2438

18868

3781X

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Divergent concomitant strabismus[STRABISMUS DIVERGENS ALIUS]

+∞

36.4

WX002

NOMESCO Finland

Sedation and analgesia

1.4

36.2

1943

14520

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.4

36.2

1671

12167

N05AH03

ATC

olanzapine; systemic

1.7

36.2

750

4596

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.8

36.2

599

3452

XCW11

NOMESCO Finland

Assessment of strabismus

60.0

36.1

WX402

NOMESCO Finland

General anaesthesia

1.3

36.0

2611

20454

B01AC04

ATC

clopidogrel; oral

1.5

35.7

1430

10142

H50.5

ICD-10 Finland

Heterophoria

+∞

35.4

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.7

35.2

617

3615

S18

ICPC

Laceration/cut

1.3

34.8

5301

45673

R03AC02

ATC

salbutamol; inhalant

1.3

34.6

6691

59221

N02BF01

ATC

gabapentin; oral

1.5

34.6

1139

7768

N05BA09

ATC

clobazam; oral

3.5

34.6

118

337

H03AA01

ATC

levothyroxine sodium; systemic

1.3

34.6

2492

19486

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

34.5

3377

27550

3501

FHL

Myotomy or tenotomy

+∞

34.3

CEC40

NOMESCO Finland

Resection and advancement of extraocular muscle

+∞

34.3

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.5

34.1

1001

6664

G44.2

ICD-10 Finland

Tension-type headache

1.4

34.0

1627

11912

N03AE01

ATC

clonazepam; systemic

1.7

34.0

599

3513

N06AA09

ATC

amitriptyline; systemic

1.6

33.9

917

5991

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

33.8

2752

21893

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.0

33.7

369

1862

L28

ICPC

Limited function/disability (L)

1.4

33.7

1878

14108

H51.2

ICD-10 Finland

Internuclear ophthalmoplegia

10.9

33.6

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

3.5

33.6

113

320

N86

ICPC

Multiple sclerosis

3.7

33.4

105

284

A02BC03

ATC

lansoprazole; oral

1.3

33.4

2854

22850

N04BC05

ATC

pramipexole; oral

1.6

33.3

741

4624

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.5

33.2

971

6458

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

33.1

1601

11740

K59.09

ICD-10 Finland

Constipation, unspecified

1.6

33.1

730

4545

D32.06

ICD-10 Finland

Benign tumor of the meninges os petrosum or clivus area

7.9

33.1

AAF00

NOMESCO Finland

Ventriculostomy

4.2

33.0

207

G80.0

ICD-10 Finland

Spastic quadriplegic cerebral palsy

12.8

33.0

G37.9

ICD-10 Finland

Demyelinating disease of central nervous system, unspecified

3.5

32.9

115

334

SPAT1153

SPAT

Removal of sutures

1.3

32.8

3194

26006

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.6

32.5

785

4995

ZXE00

NOMESCO Finland

One hour or less

1.3

32.4

4322

36576

SPAT1260

SPAT

Consultation of another employee

1.4

32.2

1894

14343

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

32.1

3358

27586

C07AA05

ATC

propranolol; systemic

1.3

31.9

2296

17923

L17

ICPC

Foot/toe symptom/complaint

1.3

31.8

3540

29295

N05AX12

ATC

aripiprazole; systemic

1.8

31.6

527

3043

XKD00

NOMESCO Finland

Uroflowmetry

1.4

31.6

1323

9451

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

31.5

1064

7291

N05BA01

ATC

diazepam; systemic, rectal

1.4

31.4

1292

9198

37872

ICD-8 Finland

Other diseases of eye, Aphakia artefacta, acquisita

12.4

31.4

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

4.9

31.4

142

R53

ICD-10 Finland

Malaise and fatigue

1.3

31.2

2964

24029

N06AB10

ATC

escitalopram; oral

1.3

31.2

2490

19722

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.6

31.1

810

5246

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

30.9

901

5983

N17

ICPC

Vertigo/dizziness

1.4

30.8

1372

9912

F82

ICD-10 Finland

Specific developmental disorder of motor function

3.8

30.7

250

N06AB04

ATC

citalopram; systemic

1.3

30.6

2185

17025

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

3.3

30.6

113

340

H52.5

ICD-10 Finland

Disorders of accommodation

5.3

30.4

116

M54.4

ICD-10 Finland

Lumbago with sciatica

1.3

30.3

2008

15477

H49.4

ICD-10 Finland

Progressive external ophthalmoplegia

+∞

30.2

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

29.7

4521

38740

H25.0

ICD-10 Finland

Senile incipient cataract

1.7

29.7

591

3582

N03AF01

ATC

carbamazepine; oral, rectal

1.8

29.4

483

2776

SPAT1240

SPAT

Therapeutic discussion

1.4

29.4

1299

9365

PA6AD

NOMESCO Finland

CT of neck arteries

1.9

29.4

391

2109

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

29.2

1120

7867

SPAT1216

SPAT

Assessment of functional ability

1.4

29.1

1442

10606

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

2.6

29.0

162

615

G71.3

ICD-10 Finland

Mitochondrial myopathy, not elsewhere classified

10.0

29.0

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

28.9

1689

12758

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

2.2

28.9

258

1208

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.4

28.8

1518

11276

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

28.8

3508

29279

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

28.7

3996

33871

T90.5

ICD-10 Finland

Sequelae of intracranial injury

2.8

28.7

144

518

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.1

28.5

279

1352

G91.8

ICD-10 Finland

Other hydrocephalus

10.7

28.5

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.6

28.2

637

3987

H062, E050,

ICD-10 Finland

7.2

27.8

ZXD05

NOMESCO Finland

Urgent procedure

1.3

27.8

3274

27201

J01DB01

ATC

cefalexin; oral

1.3

27.7

10353

97250

R20.2

ICD-10 Finland

Paraesthesia of skin

1.5

27.6

823

5490

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

2.9

27.5

126

431

XCD00

NOMESCO Finland

Clinical examination of eye in general anaesthesia

7.5

27.4

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

3.2

27.4

110

349

N28

ICPC

Limited function/disability (N)

2.4

27.3

189

795

F70.1

ICD-10 Finland

Mild mental retardation, Significant impairment of behaviour requiring attention or treatment

5.6

27.2

H02AB09

ATC

hydrocortisone; systemic

2.0

27.0

296

1497

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

2.6

26.9

161

633

R4110, ,

SPAT

1.4

26.9

1377

10177

Q12.0

ICD-10 Finland

Congenital cataract

8.9

26.7

G91.0

ICD-10 Finland

Communicating hydrocephalus

4.1

26.5

180

N05AX08

ATC

risperidone; systemic

1.5

26.5

842

5693

SPAT1262

SPAT

Handing over of treatment supplies

1.4

26.5

1647

12552

H02.2

ICD-10 Finland

Lagophthalmos

4.7

26.4

131

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.2

26.2

214

967

RL140, ,

NOMESCO Finland

5.3

26.2

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

2.6

26.2

154

601

CAC30

NOMESCO Finland

Decompression of orbit to sinuses

51.6

26.1

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

26.1

2885

23756

N06AB06

ATC

sertraline; oral

1.4

26.1

1325

9775

Z2446

NOMESCO Finland

Social worker

1.5

26.1

751

4973

UJF32

NOMESCO Finland

Coloscopy

1.3

25.9

2566

20850

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

6.5

25.8

H54.7

ICD-10 Finland

Unspecified visual loss

3.2

25.8

103

326

E0000UV, ,

ATC

1.2

25.7

4951

43300

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

25.7

964

6738

CEC80

NOMESCO Finland

Partial transposition of extraocular muscle

134.9

25.6

WX704

NOMESCO Finland

Intubation

1.5

25.5

873

5991

R11

ICD-10 Finland

Nausea and vomiting

1.4

25.4

1016

7188

C07AB07

ATC

bisoprolol; oral

1.2

25.4

4708

41011

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

25.3

4378

37857

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

25.3

1198

8733

M54.5

ICD-10 Finland

Low back pain

1.2

25.2

4244

36593

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

25.2

1393

10420

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

25.1

1428

10728

A02BC05

ATC

esomeprazole; systemic

1.2

25.1

4333

37455

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.4

25.1

1015

7196

A10AC01

ATC

insulin (human); parenteral

1.5

24.7

713

4721

N05BA04

ATC

oxazepam; oral

1.3

24.7

2832

23397

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.6

24.7

609

3893

N05AH02

ATC

clozapine; systemic

2.2

24.6

214

993

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

24.6

6543

58969

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

24.5

2169

17356

G81.1

ICD-10 Finland

Spastic hemiplegia

7.0

24.5

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

24.4

1505

11446

R52.2

ICD-10 Finland

Other chronic pain

1.8

24.4

403

2322

N29

ICPC

Neurological sympt/complt other

2.2

24.4

209

964

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.3

24.3

2323

18770

A01

ICPC

Pain general/multiple sites

1.4

24.2

1076

7759

EBA00

NOMESCO Finland

Extraction of tooth

1.2

24.0

4360

37834

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

24.0

1298

9668

3784A

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Heterophoria[ESOPHORIA]

+∞

23.9

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

23.9

4946

43480

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

23.8

2485

20291

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.7

23.7

459

2762

XKC03

NOMESCO Finland

Water cystometry

1.9

23.7

291

1531

C03CA01

ATC

furosemide; systemic

1.3

23.6

2590

21270

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.6

23.5

509

3154

A04

ICPC

Weakness/tiredness general

1.3

23.4

1839

14475

3793A

ICD-9 Finland

Other disorders of eye, Aphakia and other disorders of lens[APHAKIA]

9.3

23.4

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

23.4

4812

42244

CA1AD

NOMESCO Finland

Orbita CT

5.6

23.3

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.0

23.3

250

1255

M41.4

ICD-10 Finland

Neuromuscular scoliosis

6.8

23.2

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.2

23.2

3405

28890

CD2S4

NOMESCO Finland

Photography of eye

3.4

23.1

241

L03AX13

ATC

glatiramer acetate; parenteral

3.6

23.1

208

WX882

NOMESCO Finland

High dependency care

1.8

23.1

330

1822

E23.00

ICD-10 Finland

Panhypopituitarism

4.2

23.1

146

H26.02

ICD-10 Finland

Presenil cataract

2.0

23.0

266

1370

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

2.3

23.0

168

725

N06AX26

ATC

vortioxetine; oral

1.4

23.0

913

6447

G04BD08

ATC

solifenacin; oral

1.6

23.0

568

3633

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.4

22.9

890

6258

A10AE04

ATC

insulin glargine; parenteral

1.4

22.9

903

6368

N03AX18

ATC

lacosamide; systemic

2.9

22.9

107

371

WX725

NOMESCO Finland

Noninvasive ventilation

1.6

22.9

567

3630

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.3

22.8

2542

20904

SPAT1254

SPAT

Administration of medicine

1.3

22.8

1584

12252

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

22.8

2105

16919

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

22.7

1658

12916

M48.0

ICD-10 Finland

Spinal stenosis

1.4

22.7

1054

7656

602

Kela drug reimbursment

Children's severe malnutrition

3.3

22.6

250

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

22.5

1518

11689

R52.9

ICD-10 Finland

Pain, unspecified

1.4

22.5

1121

8238

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

1.9

22.5

285

1515

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.6

22.5

479

2956

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.1

22.4

221

1076

ZXD20

NOMESCO Finland

Day surgery

1.4

22.3

1263

9474

R50.9

ICD-10 Finland

Fever, unspecified

1.3

22.3

1701

13330

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

22.0

9101

85005

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

2.6

22.0

122

463

S06.3

ICD-10 Finland

Focal brain injury

2.6

21.9

129

505

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

2.8

21.8

105

370

L03

ICPC

Low back symptom/complaint

1.2

21.8

3352

28545

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

21.8

4341

37927

UDC00

NOMESCO Finland

Ear microscopy

1.5

21.7

771

5329

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.4

21.6

914

6528

N04AA02

ATC

biperiden; systemic

2.1

21.6

192

899

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.6

21.6

536

3432

J01FF01

ATC

clindamycin; systemic

1.2

21.6

2811

23513

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

21.5

2253

18378

H03BB01

ATC

carbimazole; oral

1.7

21.5

415

2498

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

21.4

2098

16976

A10AB05

ATC

insulin aspart; parenteral

1.5

21.3

752

5191

K02.1

ICD-10 Finland

Caries of dentine

1.2

21.2

7338

67319

T90

ICPC

Diabetes non-insulin dependent

1.3

21.1

2211

18031

N06AB03

ATC

fluoxetine; oral

1.4

21.1

1268

9598

SPAT1053

SPAT

Memory test

1.4

21.0

1073

7914

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.6

21.0

466

2905

R02

ICPC

Shortness of breath/dyspnoea

1.3

21.0

1405

10807

PA6BG

NOMESCO Finland

MRI examination of neck vasculature with high intensity magnet

3.1

20.9

288

P99

ICPC

Psychological disorders other

1.7

20.9

365

2139

PA7BD

NOMESCO Finland

CT angiography of neck and brain

2.3

20.8

155

675

J45.9

ICD-10 Finland

Asthma, unspecified

1.3

20.8

2030

16415

ZZC00

NOMESCO Finland

Graft of fascia

6.8

20.7

SPAT1325

SPAT

Vaccination

1.2

20.7

3480

29875

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.1

20.6

198

955

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

20.6

1117

8316

37003

ICD-8 Finland

Refractive errors, Anisometropia

76.7

20.6

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.7

20.6

422

2578

ZYC01

NOMESCO Finland

Remote contact by phone

1.5

20.6

680

4632

TPH07

NOMESCO Finland

Cathetrisation of artery

1.4

20.6

1054

7777

H16.0

ICD-10 Finland

Corneal ulcer

1.6

20.6

522

3360

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

2.4

20.6

134

550

F29

ICPC

Eye symptom/complaint other

1.4

20.5

1173

8809

XF400

NOMESCO Finland

ECG with 12 standard connections

1.3

20.5

1443

11175

D12

ICPC

Constipation

1.7

20.5

373

2210

R13

ICD-10 Finland

Dysphagia

1.5

20.5

668

4540

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

1.8

20.3

301

1681

C08CA01

ATC

amlodipine; oral

1.2

20.3

3551

30587

M03BX02

ATC

tizanidine; oral

1.2

20.3

7080

64885

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

2.4

20.3

135

560

F71.0

ICD-10 Finland

Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour

6.9

20.3

G04CA02

ATC

tamsulosin; oral

1.3

20.2

1811

14485

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

20.2

2301

18943

M01AX17

ATC

nimesulide; oral

1.3

20.1

2124

17327

D07AC01

ATC

betamethasone; topical

1.2

20.1

3906

33982

CBH25

NOMESCO Finland

Tarsorrhaphy

8.4

20.0

R60.0

ICD-10 Finland

Localized oedema

1.3

20.0

1209

9155

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.5

20.0

651

4424

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

2.8

19.9

100

361

R25.1

ICD-10 Finland

Tremor, unspecified

1.8

19.9

302

1699

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.2

19.9

4713

41742

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.3

19.8

1430

11115

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

19.8

1127

8459

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

2.6

19.7

116

454

G43.9

ICD-10 Finland

Migraine, unspecified

1.4

19.7

747

5228

SFA10

NOMESCO Finland

One-surface restoration

1.2

19.7

6706

61256

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.6

19.5

466

2957

3670A

ICD-9 Finland

Disorders of refraction and accommodation, Hypermetropia

104.9

19.5

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.5

19.5

565

3747

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

19.5

5401

48469

F70.9

ICD-10 Finland

Mild mental retardation, Without mention of impairment of behaviour

5.1

19.4

9530/0-C70.0

ICD-O-3

Meningioma, NOS, of cerebral meninges

3.1

19.4

264

N06AX12

ATC

bupropion; oral

1.4

19.4

850

6109

CAC10

NOMESCO Finland

Reconstruction of orbital wall using bone graft or plate

5.0

19.4

J01DA01

ATC

[U] cefalexin

1.2

19.3

6941

63640

R5140

NOMESCO Finland

Monitoring the use of the aid

1.4

19.3

1033

7675

S01ED01

ATC

timolol; ophthalmic

1.8

19.3

283

1577

J01CA04

ATC

amoxicillin; systemic

1.2

19.3

10450

99330

N04BD01

ATC

selegiline; oral

2.4

19.2

130

543

A29

ICPC

General symptom/complaint other

1.3

19.2

1386

10764

N06BA04

ATC

methylphenidate; oral

1.6

19.2

495

3198

M25.5

ICD-10 Finland

Pain in joint

1.2

19.2

3707

32201

U02

ICPC

Urinary frequency/urgency

1.3

19.1

1567

12387

J01AA02

ATC

doxycycline; systemic

1.2

19.0

8873

83120

R1250

NOMESCO Finland

Evaluation of functional capability

1.9

18.9

248

1334

CBJ40

NOMESCO Finland

Resection of levator muscle of eyelid

3.0

18.9

263

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.5

18.8

655

4509

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

4.3

18.8

112

M02AA10

ATC

ketoprofen; topical

1.3

18.8

1500

11811

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.1

18.8

186

909

SPAT1234

SPAT

Support of social functional capacity

1.6

18.7

452

2878

Z3226

NOMESCO Finland

Physiotherapist

1.3

18.7

1812

14625

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.5

18.6

550

3663

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

2.9

18.5

287

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.6

18.5

407

2532

37000

ICD-8 Finland

Refractive errors, Astigmatismus

20.7

18.5

H47.1

ICD-10 Finland

Papilloedema, unspecified

3.1

18.4

246

P03

ICPC

Feeling depressed

1.3

18.4

1288

9958

H53.8

ICD-10 Finland

Other visual disturbances

2.2

18.4

152

692

M79.1

ICD-10 Finland

Myalgia

1.3

18.4

1643

13122

A02BC01

ATC

omeprazole; systemic

1.2

18.4

2727

23066

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

2.4

18.4

124

518

A10BA02

ATC

metformin; oral

1.2

18.4

2589

21788

L03AB07

ATC

interferon beta-1a; parenteral

3.0

18.4

257

H51.9

ICD-10 Finland

Disorder of binocular movement, unspecified

15.0

18.3

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.3

18.3

1255

9674

H13

ICPC

Plugged feeling ear

1.3

18.3

1883

15300

2AB04, ,

NOMESCO Finland

4.6

18.3

G40.10

ICD-10 Finland

Simple partial seizures

2.8

18.2

306

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

1.9

18.2

219

1146

A46

ICD-10 Finland

Erysipelas

1.3

18.2

1337

10411

R35

ICD-10 Finland

Polyuria

1.5

18.2

615

4212

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

1.9

18.1

236

1267

H40.0

ICD-10 Finland

Glaucoma suspect

1.4

18.1

719

5074

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

18.0

1038

7799

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

18.0

3101

26617

L04AX07

ATC

dimethyl fumarate; oral

3.5

18.0

175

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.4

17.8

976

7278

AAE10

NOMESCO Finland

Transsphenoidal total or partial excision of intracranial lesion

3.6

17.8

162

R47.1

ICD-10 Finland

Dysarthria and anarthria

2.7

17.8

338

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.5

17.8

631

4362

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.7

17.7

300

1743

L01

ICPC

Neck symptom/complaint

1.3

17.7

1813

14719

3780X

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Convergent concomitant strabismus[STRABISMUS CONVERGENS ALIUS]

+∞

17.7

3671A

ICD-9 Finland

Disorders of refraction and accommodation, Myopia

22.7

17.7

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

1.9

17.7

215

1130

N87

ICPC

Parkinsonism

2.3

17.6

137

609

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

3.8

17.6

140

N01

ICPC

Headache

1.3

17.6

1502

11926

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

17.6

6281

57379

XCW20

NOMESCO Finland

Eye Movement Research, HESS

36.6

17.6

S97

ICPC

Chronic ulcer skin

1.5

17.5

540

3628

N02AA05

ATC

oxycodone; systemic

1.3

17.5

1587

12695

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.2

17.5

2032

16736

G20

ICD-10 Finland

Parkinson disease

1.8

17.5

253

1405

CKC12

NOMESCO Finland

Photocoagulation of retina

1.6

17.4

378

2345

G40.4

ICD-10 Finland

Other generalized epilepsy and epileptic syndromes

4.0

17.4

119

KMAK, ,

NOMESCO Finland

1.2

17.4

5834

53011

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.6

17.4

358

2193

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

17.4

3577

31197

R4110

NOMESCO Finland

Physiotherapy

1.2

17.3

2845

24291

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.5

17.3

572

3899

R4120

NOMESCO Finland

Occupational therapy

1.4

17.3

647

4518

N18

ICPC

Paralysis/weakness

2.0

17.2

177

878

ZXE20

NOMESCO Finland

More than three and less than five hours

1.3

17.2

1219

9441

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.3

17.1

1491

11865

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.2

17.1

1989

16384

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

1.8

17.0

233

1272

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

5.7

17.0

N99

ICPC

Neurological disease other

2.3

17.0

130

574

ZY010

NOMESCO Finland

Hospital outpatient

1.5

17.0

599

4136

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

2.1

16.9

164

796

N02BF02

ATC

pregabalin; oral

1.4

16.9

689

4887

WX892

NOMESCO Finland

Monitored bed care

1.4

16.9

698

4963

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.4

16.8

969

7280

K59.0

ICD-10 Finland

Constipation

1.5

16.8

552

3757

H3603, E103,

ICD-10 Finland

2.4

16.8

109

448

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.6

16.7

399

2533

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

1.8

16.7

239

1322

N05AA02

ATC

levomepromazine; systemic

1.6

16.7

358

2214

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

16.7

8541

80097

Z02.7

ICD-10 Finland

Issue of medical certificate

1.4

16.7

763

5520

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.3

16.7

1555

12476

-1, ,

NOMESCO Finland

1.2

16.7

3945

34794

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.6

16.7

359

2223

WZC00

NOMESCO Finland

Treatment plan or consultation

1.2

16.7

4277

37987

R5110, ,

SPAT

1.4

16.6

772

5606

R1260

NOMESCO Finland

Evaluation of communicative skills

2.1

16.5

146

684

WX720

NOMESCO Finland

Own respiration

1.5

16.5

470

3106

CBK11

NOMESCO Finland

Operation for lagophtalmus with implant

6.7

16.5

Z31.5

ICD-10 Finland

Genetic counselling

1.5

16.5

608

4234

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.2

16.4

1983

16393

R39.1

ICD-10 Finland

Other difficulties with micturition

1.7

16.4

282

1647

F01

ICPC

Eye pain

1.7

16.4

328

1995

34301

ICD-8 Finland

Cerebral spastic infantile paralysis, Diplegia spastica

39.9

16.3

R33

ICD-10 Finland

Retention of urine

1.4

16.2

618

4329

F29

ICD-10 Finland

Unspecified nonorganic psychosis

1.6

16.2

378

2390

D07AB02

ATC

hydrocortisone butyrate; topical

1.2

16.1

3150

27307

C10AA01

ATC

simvastatin; oral

1.2

16.1

3495

30578

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.4

16.1

829

6119

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

2.4

16.1

106

439

101

Kela drug reimbursment

Anterior pituitary hypofunction

2.6

16.1

368

CAC44

NOMESCO Finland

Combined decompression of orbit

30.0

16.1

S29

ICPC

Skin symptom/complaint other

1.2

16.0

2185

18293

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

1.8

16.0

229

1269

SFA20

NOMESCO Finland

Two-surface restoration

1.2

16.0

6970

64460

U04

ICPC

Incontinence urine

1.5

15.9

506

3424

R05

ICPC

Cough

1.2

15.8

2817

24211

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.5

15.8

537

3682

R06AE07

ATC

cetirizine; oral

1.2

15.7

5086

45956

P29

ICPC

Psychological sympt/compl other

1.3

15.7

934

7050

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

2.5

15.7

384

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.3

15.7

928

7000

S06.2

ICD-10 Finland

Diffuse brain injury

2.4

15.7

102

420

J01MA02

ATC

ciprofloxacin; systemic

1.2

15.6

3869

34217

S01ED51

ATC

timolol, combinations; ophthalmic

1.4

15.6

603

4238

D32.1

ICD-10 Finland

Benign neoplasm: Spinal meninges

4.7

15.5

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

15.5

5885

53815

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

2.5

15.4

358

P74

ICPC

Anxiety disorder/anxiety state

1.5

15.4

556

3857

RT490, ,

NOMESCO Finland

6.2

15.4

P76

ICPC

Depressive disorder

1.4

15.4

782

5762

C10AA05

ATC

atorvastatin; oral

1.2

15.4

3854

34113

H3601, E113,

ICD-10 Finland

2.2

15.3

121

542

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.2

15.3

2123

17798

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

15.3

4779

43037

L29

ICPC

Musculoskeletal sympt/complt other

1.3

15.3

910

6870

N30.0

ICD-10 Finland

Acute cystitis

1.2

15.2

1853

15324

H81

ICPC

Excessive ear wax

1.3

15.2

1597

12991

TKC22

NOMESCO Finland

Catheterisation instruction

1.9

15.2

191

1017

N05CF02

ATC

zolpidem; oral

1.2

15.1

1708

14006

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

1.9

15.1

187

989

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

1.9

15.1

199

1074

3768

FHL

Eye examination under general anesthesia

17.7

15.1

M79.7

ICD-10 Finland

Fibromyalgia

1.6

15.1

359

2280

D32.9

ICD-10 Finland

Benign neoplasm: Meninges, unspecified

3.4

15.1

156

S02.30

ICD-10 Finland

Fracture of orbital floor, closed

2.5

15.1

368

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.2

15.0

2273

19222

114

Kela drug reimbursment

Glaucoma

1.4

15.0

657

4723

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.1

14.9

141

679

XX4AW, ,

NOMESCO Finland

3.2

14.9

177

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.4

14.9

608

4316

-, ,

ICD-10 Finland

1.8

14.9

201

1095

R5130, ,

SPAT

3.4

14.8

153

W19

ICD-10 Finland

Unspecified fall

1.3

14.8

988

7585

R4130

NOMESCO Finland

Speech therapy

1.7

14.8

256

1500

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.3

14.7

1050

8133

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

2.2

14.7

120

545

J01EA01

ATC

trimethoprim; systemic

1.2

14.7

2623

22530

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

2.2

14.7

114

508

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

2.4

14.7

415

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.3

14.6

985

7572

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.3

14.6

1103

8614

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.5

14.6

493

3378

H49.3

ICD-10 Finland

Total (external) ophthalmoplegia

+∞

14.6

CEC85

NOMESCO Finland

Combined correction of cyclodeviation

+∞

14.6

WX400

NOMESCO Finland

Inhalation anesthesy

1.5

14.6

433

2890

P20

ICPC

Memory disturbance

1.3

14.5

1084

8448

H3603, E113,

ICD-10 Finland

2.7

14.5

276

S01FA01

ATC

atropine; ophthalmic

3.4

14.5

155

R01AD09

ATC

mometasone; nasal

1.2

14.5

5205

47312

H52.4

ICD-10 Finland

Presbyopia

1.6

14.5

355

2270

D32.0

ICD-10 Finland

Benign neoplasm: Cerebral meninges

3.7

14.5

122

H02AB07

ATC

prednisone; oral

1.3

14.4

1219

9656

SPAT1307

SPAT

Psychosocial counselling and guidance

1.4

14.4

745

5504

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.3

14.4

1282

10223

SPAT1097

SPAT

Recording of ECG

1.3

14.4

1236

9813

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.2

14.3

2815

24381

M54.6

ICD-10 Finland

Pain in thoracic spine

1.4

14.3

776

5777

H54.4

ICD-10 Finland

Blindness, monocular

3.9

14.3

105

G04BD09

ATC

trospium; oral

1.8

14.3

199

1095

H02.3

ICD-10 Finland

Blepharochalasis

1.4

14.2

544

3815

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.4

14.2

527

3674

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.3

14.2

868

6579

A10AB01

ATC

insulin (human); parenteral

1.6

14.2

319

2000

37404

ICD-8 Finland

Cataract, Secundaria

19.1

14.2

M03BC01

ATC

orphenadrine (citrate); systemic

1.2

14.2

2288

19460

SPAT1101

SPAT

Orthostatic test

1.6

14.2

323

2032

G46.3*I67.9

ICD-10 Finland

Brain stem stroke syndrome (I60-I67+)

3.7

14.1

115

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

1.8

14.1

226

1297

N04BC04

ATC

ropinirole; oral

2.3

14.1

104

454

P06

ICPC

Sleep disturbance

1.3

14.0

1424

11532

SGA01

NOMESCO Finland

Emergency treatment

1.2

14.0

1776

14740

SCA02

NOMESCO Finland

Preventive oral health care

1.3

14.0

1318

10581

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.3

14.0

902

6891

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

1.8

14.0

219

1248

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.5

14.0

419

2803

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.6

13.9

320

2018

C09CA06

ATC

candesartan; oral

1.2

13.9

2382

20371

SPAT1139

SPAT

Nutrition survey

1.6

13.9

300

1863

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.5

13.9

439

2969

N05CD07

ATC

temazepam; oral

1.3

13.8

899

6875

OAB50, ,

SPAT

1.4

13.8

751

5595

XKD03

NOMESCO Finland

Urethral pressure profilometry

1.8

13.8

187

1021

H01AC01

ATC

somatropin; parenteral

2.8

13.7

245

F80.1

ICD-10 Finland

Expressive language disorder

2.2

13.7

117

542

R32

ICD-10 Finland

Unspecified urinary incontinence

1.7

13.7

242

1426

R60.9

ICD-10 Finland

Oedema, unspecified

1.4

13.7

519

3634

J45.1

ICD-10 Finland

Nonallergic asthma

1.4

13.7

708

5230

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

2.4

13.7

361

AA1BD

NOMESCO Finland

Extensive CT of head and brain

1.8

13.6

206

1162

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

1.5

13.6

368

2409

EB1VA, ,

NOMESCO Finland

1.2

13.6

1906

15985

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.4

13.5

518

3634

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

13.5

2719

23576

U07

ICPC

Urine symptom/complaint other

1.3

13.5

801

6042

A02BA02

ATC

ranitidine; systemic

1.2

13.5

1644

13582

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

1.5

13.5

417

2808

R51.81

ICD-10 Finland

Facial pain NOS

1.7

13.4

238

1404

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

1.7

13.4

228

1330

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

1.7

13.4

236

1390

A10AA02, ,

ATC

1.6

13.4

273

1671

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.5

13.4

424

2869

G80.3

ICD-10 Finland

Dyskinetic cerebral palsy

25.7

13.3

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

2.1

13.3

117

549

102

Kela drug reimbursment

Diabetes insipidus

4.2

13.3

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.2

13.2

2718

23610

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

2.0

13.2

138

691

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.3

13.2

1005

7856

IGY02

NOMESCO Finland

Psychiatric monitoring contact

1.5

13.2

390

2603

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.3

13.1

1284

10350

L04AX01

ATC

azathioprine; systemic

1.5

13.1

416

2814

164

Kela drug reimbursment

Fingolimod

3.3

13.1

150

R15

ICD-10 Finland

Faecal incontinence

1.7

13.1

243

1451

A10BJ06

ATC

semaglutide; parenteral

1.5

13.1

465

3217

D11

ICPC

Diarrhoea

1.3

13.1

1363

11068

D21

ICPC

Swallowing problem

2.0

13.1

136

679

H02AB04

ATC

methylprednisolone; systemic

1.3

13.1

1327

10744

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

13.1

346

2254

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.3

13.0

1273

10268

R55

ICD-10 Finland

Syncope and collapse

1.3

13.0

992

7758

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.4

12.9

625

4567

A10AE05

ATC

insulin detemir; parenteral

1.4

12.9

482

3366

H26.2

ICD-10 Finland

Complicated cataract

2.1

12.9

113

529

C09CA01

ATC

losartan; oral

1.2

12.9

2273

19470

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.4

12.9

696

5177

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

1.9

12.9

170

920

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.2

12.9

1832

15378

G43.3

ICD-10 Finland

Complicated migraine

1.8

12.9

198

1123

AA5HE

NOMESCO Finland

Brain ultrasound examination in a child

2.7

12.9

237

CA1BM

NOMESCO Finland

Eye and orbita MRI examination with 3 Tesla magnet

19.0

12.9

M02AA07

ATC

piroxicam; topical

1.2

12.8

3306

29241

J01MA12

ATC

levofloxacin; systemic

1.2

12.8

1632

13545

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

1.9

12.8

146

753

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.4

12.8

513

3630

AWB00

NOMESCO Finland

Reoperation for superficial infection in surgery of the nervous system

4.3

12.8

SFA30

NOMESCO Finland

Three-surface restoration

1.2

12.8

4495

40691

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.3

12.8

743

5591

F72.0

ICD-10 Finland

Severe mental retardation, with the statement of no, or minimal, impairment of behaviour

11.5

12.7

J01FA06

ATC

roxithromycin; oral

1.2

12.7

3985

35770

4AA23, ,

NOMESCO Finland

5.7

12.7

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.3

12.6

941

7335

T82

ICPC

Obesity

1.5

12.6

441

3044

C10AA03

ATC

pravastatin; oral

1.4

12.6

540

3868

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.5

12.6

361

2393

A98

ICPC

Health maint/preventive medicine

1.3

12.6

12782

125226

F25.11

ICD-10 Finland

Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms

3.6

12.6

115

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.2

12.6

1881

15864

G52.8

ICD-10 Finland

Disorders of other specified cranial nerves

15.4

12.6

ADB00

NOMESCO Finland

Implantation of vagus nerve stimulating device

5.9

12.5

3502

FHL

Plication, duplication or fade surgery

+∞

12.5

CED00

NOMESCO Finland

Plication of extraocular muscle

+∞

12.5

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.2

12.5

1330

10829

3430A

ICD-9 Finland

Infantile cerebral palsy, Diplegic

17.2

12.5

K03.66

ICD-10 Finland

Tooth plaque

1.3

12.4

844

6493

R01AD01

ATC

beclometasone; nasal

1.2

12.4

1448

11906

SPAT1365

SPAT

Health check-up performed during first study year due to special need in students of upper secondary schools or vocational schools

2.8

12.4

214

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

1.5

12.3

326

2124

H3600, E113,

ICD-10 Finland

2.3

12.3

398

H57.0

ICD-10 Finland

Anomalies of pupillary function

2.5

12.3

283

H29

ICPC

Ear symptom/complaint other

1.3

12.3

1195

9625

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

1.5

12.3

327

2134

WZA90

NOMESCO Finland

Other medical or dental certificate

1.2

12.3

2592

22549

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

2.3

12.2

399

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.4

12.2

478

3369

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.5

12.2

356

2369

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

1.5

12.2

378

2547

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.5

12.2

373

2507

R51

ICD-10 Finland

Headache

1.4

12.2

620

4571

N02CC03

ATC

zolmitriptan; nasal, oral

1.4

12.1

528

3792

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

2.2

12.1

420

N06AB05

ATC

paroxetine; oral

1.4

12.1

545

3938

G04BD07

ATC

tolterodine; oral

1.5

12.1

353

2350

L13

ICPC

Hip symptom/complaint

1.2

12.1

1807

15238

N05AF03

ATC

chlorprothixene; systemic

1.7

12.1

235

1423

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

1.7

12.1

192

1101

G50.1

ICD-10 Finland

Atypical facial pain

1.8

12.1

168

926

Q66.0

ICD-10 Finland

Talipes equinovarus

4.5

12.0

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.4

12.0

581

4247

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.3

12.0

1252

10165

Z01.2

ICD-10 Finland

Dental examination

1.1

12.0

5674

52345

R03DC03

ATC

montelukast; oral

1.2

12.0

1733

14566

JDB10

NOMESCO Finland

Percutaneous gastrostomy

2.1

12.0

105

493

M70.6

ICD-10 Finland

Trochanteric bursitis

1.3

12.0

1203

9729

H46

ICD-10 Finland

Optic neuritis

2.2

11.9

435

N06AX03

ATC

mianserin; oral

1.5

11.9

394

2689

XCH00

NOMESCO Finland

Eye pressure measurement

1.5

11.9

405

2782

WX142

NOMESCO Finland

Sub-tenon anesthesy

2.5

11.9

288

K07.60

ICD-10 Finland

Snapping jaw

1.4

11.9

541

3917

N05AB03

ATC

perphenazine; systemic, rectal

1.6

11.8

303

1960

S22

ICPC

Nail symptom/complaint

1.4

11.8

657

4909

J02AC01

ATC

fluconazole; systemic

1.1

11.8

4253

38505

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

2.0

11.8

127

643

R03BA05

ATC

fluticasone; inhalant

1.2

11.8

1913

16252

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

1.6

11.8

254

1578

XX3DW

NOMESCO Finland

Time consuming IT work

1.3

11.8

906

7088

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

1.9

11.8

154

832

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

1.7

11.8

197

1146

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.4

11.8

429

2986

G81.9

ICD-10 Finland

Hemiplegia, unspecified

2.2

11.7

432

S01CA03

ATC

hydrocortisone and antiinfectives; ophthalmic

2.2

11.7

432

H35.1

ICD-10 Finland

Retinopathy of prematurity

5.8

11.7

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

2.0

11.7

116

570

IEV99

NOMESCO Finland

Other psychiatric network intervention

2.2

11.7

413

WX702

NOMESCO Finland

Supraglottic ventilation device

1.4

11.7

530

3834

F71.1

ICD-10 Finland

Moderate mental retardation, significant impairment of behaviour requiring attention or treatment

8.9

11.7

CKC15

NOMESCO Finland

Panretinal photocoagulation

2.4

11.6

303

N05CD08

ATC

midazolam; nasal, systemic

1.7

11.6

194

1128

F81.3

ICD-10 Finland

Mixed disorder of scholastic skills

2.6

11.6

256

N03AG04

ATC

vigabatrin; oral

4.3

11.6

JN3AD

NOMESCO Finland

Abdominal CT examination

1.2

11.6

1226

9969

D43.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, infratentorial

4.0

11.6

RS142, ,

NOMESCO Finland

3.7

11.6

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

2.5

11.6

298

WX290

NOMESCO Finland

Other blockage of nerve

1.1

11.5

5732

52998

K08.3

ICD-10 Finland

Retained dental root

1.3

11.5

687

5189

CAC20

NOMESCO Finland

Lateral decompression of orbit

22.8

11.5

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

1.6

11.5

267

1690

CBJ30

NOMESCO Finland

Plastic repair of levator aponeurosis of eyelid

3.0

11.5

163

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.3

11.5

713

5419

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.2

11.5

2837

24981

CEE00

NOMESCO Finland

Posterior fixation suture of extraocular muscle

+∞

11.4

3506

FHL

Resection of two muscles

+∞

11.4

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

2.9

11.4

174

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

1.6

11.4

231

1413

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.2

11.4

1197

9723

N03AB02

ATC

phenytoin; systemic

2.2

11.4

405

F79.1

ICD-10 Finland

Unspecified mental retardation, significant impairment of behaviour requiring attention or treatment

5.7

11.4

I60.0

ICD-10 Finland

Subarachnoid haemorrhage from carotid siphon and bifurcation

3.4

11.4

118

A10AB04

ATC

insulin lispro; parenteral

1.6

11.4

282

1812

181

Kela drug reimbursment

Retigabine and vigabatrin

4.8

11.4

RT150, ,

NOMESCO Finland

2.9

11.3

175

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

2.0

11.3

120

605

Z87.6

ICD-10 Finland

Personal history of certain conditions arising in the perinatal period

2.3

11.3

344

RD210, ,

NOMESCO Finland

1.7

11.3

197

1160

ZXC95

NOMESCO Finland

Use of surgical navigator

2.0

11.3

114

565

G52.9

ICD-10 Finland

Cranial nerve disorder, unspecified

15.0

11.3

353

Kela drug reimbursment

Cladribine and fingolimod

3.2

11.3

139

R03BA02

ATC

budesonide; inhalant

1.2

11.3

1821

15464

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.4

11.2

432

3037

RT190, ,

NOMESCO Finland

8.3

11.2

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.3

11.2

1078

8670

UDM02

NOMESCO Finland

Sinoscopy

1.7

11.2

199

1177

A10AA01, ,

ATC

1.6

11.2

223

1359

H01

ICPC

Ear pain/earache

1.2

11.2

1385

11454

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.2

11.2

2458

21432

H35.38

ICD-10 Finland

Preretinal fibrosis of the macula

1.6

11.2

279

1796

S10

ICPC

Boil/carbuncle

1.4

11.2

567

4179

S01

ICPC

Pain/tenderness of skin

1.4

11.1

447

3167

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

1.7

11.1

207

1240

WX872

NOMESCO Finland

Intensive care

1.5

11.1

394

2728

NFL22

NOMESCO Finland

Myotomy or tenotomy of hip or thigh

4.4

11.1

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.3

11.1

1050

8429

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

1.5

11.1

350

2369

R06.5

ICD-10 Finland

Mouth breathing

1.3

11.1

855

6693

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

2.4

11.1

310

H25.8

ICD-10 Finland

Other senile cataract

1.3

11.0

806

6264

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.3

11.0

867

6803

D01

ICPC

Abdominal pain/cramps general

1.2

11.0

1400

11611

P01AB01

ATC

metronidazole; oral, rectal

1.1

10.9

4220

38340

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.5

10.9

301

1980

F61.0

ICD-10 Finland

Mixed personality disorders

1.8

10.9

170

969

PA2MT

NOMESCO Finland

Endovascular closure of very extensive brain aneurysm

4.2

10.9

Z00.0

ICD-10 Finland

General medical examination

1.2

10.9

1998

17151

3431A

ICD-9 Finland

Infantile cerebral palsy, Hemiplegic

13.8

10.9

L16

ICPC

Ankle symptom/complaint

1.2

10.9

1304

10745

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

2.7

10.9

201

A10AD01

ATC

insulin (human); parenteral

1.8

10.9

146

796

L03AB08

ATC

interferon beta-1b; parenteral

3.5

10.9

107

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.3

10.9

814

6347

G50.0

ICD-10 Finland

Trigeminal neuralgia

1.8

10.9

161

905

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

2.0

10.9

115

580

F60.9

ICD-10 Finland

Personality disorder, unspecified

1.9

10.8

133

705

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.2

10.8

1849

15775

R01BA52

ATC

pseudoephedrine, combinations; oral

1.2

10.8

2830

25009

K90

ICPC

Stroke/cerebrovascular accident

1.7

10.8

212

1288

R5599

NOMESCO Finland

Other rehabilitation service

1.6

10.8

255

1621

N06AA10

ATC

nortriptyline; systemic

1.7

10.8

184

1077

AEA50

NOMESCO Finland

Adjustment of implanted neurostimulator

2.9

10.8

164

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

2.3

10.8

358

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

1.7

10.7

201

1207

37405

ICD-8 Finland

Cataract, Traumatica

8.8

10.7

S01EE01

ATC

latanoprost; ophthalmic

1.4

10.7

460

3299

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

2.4

10.7

291

XCW10

NOMESCO Finland

Assessment of vision

1.9

10.6

139

752

78110

ICD-8 Finland

Other symptoms referable to nervous system and special senses, Diplopia

21.4

10.6

J01FA10

ATC

azithromycin; systemic

1.1

10.6

6853

64271

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

1.8

10.6

140

760

D07AA02

ATC

hydrocortisone; topical

1.2

10.6

1507

12637

Q25.0

ICD-10 Finland

Patent ductus arteriosus

3.2

10.6

124

SPAT1255

SPAT

Intravenous administration of medicine

1.4

10.6

568

4226

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.5

10.5

273

1774

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.2

10.5

2294

19984

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

1.6

10.5

236

1484

F20.9

ICD-10 Finland

Schizophrenia, unspecified

1.7

10.5

182

1071

XCW12

NOMESCO Finland

Assessment of colour vision

8.4

10.5

M01AH01

ATC

celecoxib; oral

1.2

10.5

1563

13169

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

2.6

10.5

217

R06AX22

ATC

ebastine; oral

1.2

10.4

1705

14485

AAF99

NOMESCO Finland

Other shunt operation on ventricle of brain or intracerebral cyst

4.3

10.4

9530/0-C70.9

ICD-O-3

Meningioma, NOS, of meninges, NOS

4.0

10.4

P22.0

ICD-10 Finland

Respiratory distress syndrome of newborn

4.6

10.4

X58

ICD-10 Finland

Exposure to other specified factors

1.2

10.4

1572

13261

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

1.9

10.4

134

723

N04BB01

ATC

amantadine; oral

1.9

10.3

126

667

SPAT1252

SPAT

Overall medication plan or its review

1.4

10.3

524

3863

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.4

10.3

569

4249

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.3

10.3

737

5712

S02.11

ICD-10 Finland

Fracture of base of skull, open

3.3

10.3

116

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.2

10.3

1300

10772

CBK00

NOMESCO Finland

Myotomy or resection of tarsal muscle or levator muscle of eyelid for correction of retraction

32.4

10.3

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.0

10.3

101

496

TKC20

NOMESCO Finland

Catheterisation of bladder

1.4

10.3

520

3832

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.2

10.3

1152

9427

M01AG02

ATC

tolfenamic acid; oral, rectal

1.2

10.3

1406

11746

SAA04

NOMESCO Finland

Special examination of mouth

1.4

10.3

545

4047

SPAT1211

SPAT

Application of soft bandage

1.3

10.3

826

6502

IAB01, ,

SPAT

2.3

10.3

315

C10AC01

ATC

colestyramine; oral

1.6

10.2

246

1571

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.3

10.2

737

5718

OAB43, ,

SPAT

0.9

10.2

3207

35478

A03

ICPC

Fever

1.2

10.2

2068

17898

SPAT1231

SPAT

Assessment of adjustments needed in living environment

1.9

10.2

133

719

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

1.8

10.2

155

878

7433A

ICD-9 Finland

Congenital anomalies of eye, Congenital cataract and lens anomalies

18.7

10.2

SPAT1396

SPAT

Meeting with multidisciplinary group of experts

2.2

10.2

347

H40.11

ICD-10 Finland

Low pressure glaucoma

1.8

10.2

157

893

ZX120

NOMESCO Finland

Intravenous

1.3

10.2

825

6498

L05

ICPC

Flank/axilla symptom/complaint

1.3

10.2

600

4525

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

3.1

10.2

132

A10AD05

ATC

insulin aspart; parenteral

1.9

10.2

120

628

W10

ICD-10 Finland

Fall on and from stairs and steps

1.4

10.2

472

3429

A10BJ05

ATC

dulaglutide; parenteral

1.7

10.2

161

923

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.4

10.2

396

2791

S80.0

ICD-10 Finland

Contusion of knee

1.3

10.2

792

6207

H33.2

ICD-10 Finland

Serous retinal detachment

3.6

10.2

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

2.5

10.2

232

E66.01

ICD-10 Finland

Obesity due to excess calories

1.3

10.1

998

8049

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.3

10.1

923

7377

N88

ICPC

Epilepsy

2.3

10.1

317

R03BA01

ATC

beclometasone; inhalant

1.2

10.1

1272

10540

N40

ICD-10 Finland

Hyperplasia of prostate

1.2

10.1

1502

12652

L12

ICPC

Hand/finger symptom/complaint

1.2

10.0

1875

16117

PA6AG

NOMESCO Finland

Limited MRI examination of neck vasculature with high intensity magnet

2.4

10.0

263

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.1

10.0

4394

40198

WF099

NOMESCO Finland

Other radiotherapy

2.6

10.0

216

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

2.2

10.0

382

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

1.9

10.0

121

639

NF1AA

NOMESCO Finland

Hip X-ray examination

1.3

10.0

740

5762

C09AA05

ATC

ramipril; oral

1.2

10.0

2002

17311

G72.9

ICD-10 Finland

Myopathy, unspecified

2.3

10.0

319

-50

ICPC

Medication/prescr/renewal

1.5

10.0

336

2306

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.1

10.0

3975

36145

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.5

9.9

279

1845

D33.00

ICD-10 Finland

Medial pilosytic astrocytoma of the cerebrum

4.6

9.9

8000/0-C70.0

ICD-O-3

Neoplasm, benign of cerebral meninges

3.1

9.9

129

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.2

9.9

1086

8864

G82.2

ICD-10 Finland

Paraplegia, unspecified

2.9

9.9

161

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.4

9.9

459

3336

A10BH01

ATC

sitagliptin; oral

1.3

9.9

727

5656

L19

ICPC

Muscle symptom/complaint NOS

1.5

9.9

276

1823

S22.3

ICD-10 Finland

Fracture of rib

1.3

9.9

611

4642

R01AD58

ATC

fluticasone, combinations; nasal

1.2

9.9

2818

25043

R63.4

ICD-10 Finland

Abnormal weight loss

1.5

9.9

336

2311

CBB10

NOMESCO Finland

Excision of redundant skin of eyelid

1.7

9.9

158

910

34300

ICD-8 Finland

Cerebral spastic infantile paralysis, Hemiplegia spastica

16.6

9.8

AA3AD

NOMESCO Finland

CT of face

2.2

9.8

385

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

2.2

9.8

385

RF120, ,

NOMESCO Finland

2.0

9.8

105

532

C08CA02

ATC

felodipine; oral

1.3

9.8

694

5372

CKC10

NOMESCO Finland

Local photocoagulation of retina

1.8

9.8

128

693

H43.1

ICD-10 Finland

Vitreous haemorrhage

1.6

9.8

195

1190

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.5

9.8

342

2363

SPAT1243

SPAT

Psychiatric/psychological examination

1.5

9.8

289

1931

A11

ICPC

Chest pain NOS

1.3

9.8

764

5991

T89

ICPC

Diabetes insulin dependent

1.4

9.8

381

2687

D86.3

ICD-10 Finland

Sarcoidosis of skin

3.4

9.8

100

78112

ICD-8 Finland

Other symptoms referable to nervous system and special senses, Nystagmus

25.9

9.8

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

2.1

9.7

393

N03AX22

ATC

perampanel; oral

3.6

9.7

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.2

9.7

1142

9391

C01DA14

ATC

isosorbide mononitrate; oral

1.2

9.7

1086

8883

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.3

9.7

754

5909

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.3

9.7

726

5662

37898

ICD-8 Finland

Other diseases of eye, Disease of eyeball, ocular muscle and orbit NEC

4.5

9.7

CBB11

NOMESCO Finland

Resection of lax skin in upper eyelid

1.6

9.7

215

1348

E000001, ,

ATC

1.2

9.7

2036

17670

N05BE01

ATC

buspirone; oral

1.5

9.7

257

1679

NXL00

NOMESCO Finland

Biopsy of muscle

2.8

9.7

163

N03AX23

ATC

brivaracetam; systemic

3.1

9.7

131

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.3

9.7

841

6684

G44.8

ICD-10 Finland

Other specified headache syndromes

1.7

9.7

158

915

A10BB12

ATC

glimepiride; oral

1.4

9.7

437

3163

BAA60

NOMESCO Finland

Total thyroidectomy

1.6

9.7

213

1334

H65.3

ICD-10 Finland

Chronic mucoid otitis media

1.5

9.7

276

1833

3007

Kela drug reimbursment

Erenumab and fremanezumab

1.8

9.6

141

791

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.3

9.6

825

6545

L04AA27

ATC

[U] fingolimod

3.4

9.6

101

E66.8

ICD-10 Finland

Other obesity

1.3

9.6

544

4079

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.4

9.6

451

3284

G04BD04

ATC

oxybutynin; oral, transdermal

1.4

9.6

395

2813

R01AD08

ATC

fluticasone; nasal

1.1

9.6

2971

26548

NJ3CG

NOMESCO Finland

Extensive MRI examination of extremities with median high magnet

2.8

9.6

164

H44.5

ICD-10 Finland

Degenerated conditions of globe

5.3

9.6

N04BA03

ATC

levodopa, decarboxylase inhibitor and COMT inhibitor; oral

2.2

9.6

344

AA4DG

NOMESCO Finland

Very extensive MRI examination of sella turcica with high intensity magnet

4.2

9.6

SPAT1246

SPAT

Screening of depression or other psychiatric problem

1.4

9.6

453

3305

L04

ICPC

Chest symptom/complaint

1.3

9.5

617

4719

Q21.08

ICD-10 Finland

Other specifed ventricular septal defect

2.6

9.5

210

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

1.6

9.5

213

1339

PA2AD

NOMESCO Finland

CT angiography of brain

2.1

9.5

430

B01AC07

ATC

dipyridamole; systemic

1.5

9.5

252

1647

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

2.4

9.5

252

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

1.5

9.5

251

1640

N03AF03

ATC

rufinamide; oral

15.0

9.5

K04.0

ICD-10 Finland

Pulpitis

1.3

9.5

937

7562

SPAT1377

SPAT

Polysomnography

1.5

9.5

272

1809

R00.2

ICD-10 Finland

Palpitations

1.3

9.4

790

6252

H17.8

ICD-10 Finland

Other corneal scars and opacities

3.0

9.4

128

104

Kela drug reimbursment

Thyroid insufficiency

1.3

9.4

585

4449

M54.2

ICD-10 Finland

Cervicalgia

1.3

9.4

778

6147

E03.89

ICD-10 Finland

Other specified hypothyroidism

1.4

9.4

352

2467

S04.1

ICD-10 Finland

Injury of oculomotor nerve

29.9

9.4

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

2.3

9.4

278

F34.1

ICD-10 Finland

Dysthymia

1.4

9.4

353

2476

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.2

9.3

2241

19651

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

2.4

9.3

266

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

1.7

9.3

174

1045

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

1.7

9.3

153

888

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

1.7

9.3

162

956

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

1.6

9.3

181

1100

SPAT1210

SPAT

Application of cast or individual aid

1.4

9.3

357

2514

CA1DG

NOMESCO Finland

Eye and orbita very extensive MRI examination with high intensity magnet

4.3

9.3

J01CA08

ATC

pivmecillinam; oral

1.1

9.3

4382

40232

H47.7

ICD-10 Finland

Disorder of visual pathways, unspecified

10.6

9.2

CBD99

NOMESCO Finland

Other plastic reconstruction of eyelid

4.7

9.2

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

1.5

9.2

256

1690

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.4

9.2

398

2860

E66.00

ICD-10 Finland

Metabolic syndrome

1.4

9.2

478

3541

L04AA31

ATC

[U] teriflunomide

3.0

9.2

130

XQ800

NOMESCO Finland

Prick test

1.3

9.2

758

5988

C10AA07

ATC

rosuvastatin; oral

1.1

9.2

3100

27855

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.4

9.2

401

2888

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

2.7

9.2

174

Z50.5

ICD-10 Finland

Speech therapy

1.7

9.1

146

842

G41.9

ICD-10 Finland

Status epilepticus, unspecified

2.5

9.1

209

C09AA02

ATC

enalapril; systemic

1.2

9.1

1494

12693

S21

ICPC

Skin texture symptom/complaint

1.2

9.1

1507

12814

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.3

9.1

798

6351

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.3

9.1

520

3909

R68.2

ICD-10 Finland

Dry mouth, unspecified

2.2

9.1

320

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.6

9.1

200

1254

S70.0

ICD-10 Finland

Contusion of hip

1.4

9.1

323

2243

M01AE02

ATC

naproxen; oral, rectal

1.1

9.1

6502

61118

A08

ICPC

Swelling

1.4

9.1

469

3472

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.4

9.0

464

3431

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.3

9.0

726

5717

Q87.88

ICD-10 Finland

Other specified congenital malformation syndromes, not elsewhere classified

4.4

9.0

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

1.5

9.0

305

2097

K05.18

ICD-10 Finland

Chronic gingivitis

1.3

9.0

767

6082

A01AB09

ATC

miconazole; local oral

1.3

9.0

737

5816

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.3

9.0

535

4044

IGY99

NOMESCO Finland

Other psychiatric treatment contact

1.5

8.9

260

1734

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.3

8.9

521

3928

Z08

ICPC

Social welfare problem

1.8

8.9

123

679

J01CF05

ATC

flucloxacillin; systemic

1.3

8.9

678

5302

3242

FHL

Levator resection

18.5

8.9

N05AD01

ATC

haloperidol; systemic

1.5

8.9

230

1496

AEA20

NOMESCO Finland

Removal of impulse generator of stimulation device in the nervous system

3.8

8.9

H3602, E113,

ICD-10 Finland

3.8

8.9

M54.3

ICD-10 Finland

Sciatica

1.3

8.9

518

3905

R09

ICPC

Sinus symptom/complaint

1.3

8.9

857

6899

F80.8

ICD-10 Finland

Other developmental disorders of speech and language

3.1

8.9

117

H30.9

ICD-10 Finland

Chorioretinal inflammation, unspecified

4.2

8.9

S01EC01

ATC

acetazolamide; systemic

1.7

8.8

171

1038

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

1.7

8.8

157

932

R25.2

ICD-10 Finland

Cramp and spasm

1.6

8.8

222

1435

SDA03

NOMESCO Finland

Periodontal treatment

1.1

8.8

4579

42236

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

1.5

8.8

276

1869

301

Kela drug reimbursment

Growth hormone

3.2

8.8

107

H44.2

ICD-10 Finland

Degenerative myopia

3.7

8.8

X78

ICD-10 Finland

Intentional self-harm by sharp object

2.2

8.8

318

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

2.4

8.8

237

DFF00

NOMESCO Finland

Pure tone audiometry

1.3

8.8

871

7034

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

2.0

8.8

471

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.2

8.8

927

7539

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.3

8.8

782

6238

L86

ICPC

Back syndrome with radiating pain

1.3

8.8

558

4261

CBJ10

NOMESCO Finland

Fascia plate sling or synthetic material for ptosis correction

9.4

8.7

Q99.8

ICD-10 Finland

Other specified chromosome abnormalities

4.0

8.7

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.3

8.7

776

6188

K30

ICD-10 Finland

Functional dyspepsia

1.2

8.7

1100

9115

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.2

8.7

1118

9281

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.5

8.7

292

2006

S01BC05

ATC

ketorolac; ophthalmic

1.5

8.7

254

1697

RL130, ,

NOMESCO Finland

2.7

8.7

162

H15.0

ICD-10 Finland

Scleritis

2.7

8.7

162

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

1.6

8.7

208

1331

-31

ICPC

Medical examin/health eval partial

1.3

8.7

603

4661

P52.2

ICD-10 Finland

Intraventricular (nontraumatic) haemorrhage, grade 3, and grade 4 of fetus and newborn

49.9

8.7

74439

ICD-8 Finland

Congenital anomalies of eye, Cataracta NUD

14.0

8.7

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

1.6

8.7

210

1347

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.3

8.6

534

4060

N89

ICPC

Migraine

1.4

8.6

425

3123

A05

ICPC

Feeling ill

1.3

8.6

730

5787

WX003

NOMESCO Finland

Sedation or analgesia orally, rectally or intramuscularly without general anesthesia

1.9

8.6

502

CS1H4

NOMESCO Finland

Retinal nerve fibre layer imaging

1.7

8.6

160

962

L02

ICPC

Back symptom/complaint

1.2

8.6

1090

9039

GEC24

NOMESCO Finland

Thoracoscopic thymectomy

4.4

8.6

S01FA04

ATC

cyclopentolate; ophthalmic

2.0

8.6

441

P01

ICPC

Feeling anxious/nervous/tense

1.2

8.6

1609

13831

J05AB01

ATC

aciclovir; systemic

1.2

8.6

2155

18958

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

1.5

8.5

238

1574

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

1.5

8.5

262

1768

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.3

8.5

676

5314

G04CB01

ATC

finasteride; oral

1.3

8.5

694

5475

N31.0

ICD-10 Finland

Uninhibited neuropathic bladder, not elsewhere classified

2.9

8.5

136

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.4

8.5

381

2757

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

2.1

8.5

342

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.5

8.5

267

1811

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.1

8.5

6408

60316

J01DA09

ATC

[U] cefadroxil

1.1

8.5

2623

23415

AA1AA

NOMESCO Finland

Head X-ray examination

2.1

8.5

336

S02.10

ICD-10 Finland

Fracture of base of skull, closed

2.7

8.5

153

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

1.5

8.5

264

1788

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

3.5

8.5

R04

ICPC

Breathing problem other

1.4

8.4

350

2499

H33.0

ICD-10 Finland

Retinal detachment with retinal break

1.6

8.4

209

1347

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.2

8.4

1085

9006

N06AX05

ATC

trazodone; oral

1.5

8.4

219

1427

A03FA01

ATC

metoclopramide; systemic, rectal

1.2

8.4

2116

18608

U05

ICPC

Urination problems other

1.4

8.4

428

3161

H36.09

ICD-10 Finland

Diabetic retinopathy (E10-E14+ with common fourth character .3)

2.7

8.4

159

SPAT1058

SPAT

PEF monitoring instruction

1.3

8.4

695

5492

D31.3

ICD-10 Finland

Benign neoplasm: Choroid

1.7

8.4

133

765

G40

ICD-10 Finland

Epilepsy

2.0

8.4

437

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

2.1

8.4

337

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.4

8.4

401

2933

NHQ40

NOMESCO Finland

Amputation of toe

1.9

8.4

107

577

R1420, ,

SPAT

2.4

8.4

236

Z71.8

ICD-10 Finland

Other specified counselling

1.1

8.4

3884

35566

L29.9

ICD-10 Finland

Pruritus, unspecified

1.5

8.4

257

1735

RS221, ,

NOMESCO Finland

1.7

8.3

131

752

R03AC13

ATC

formoterol; inhalant

1.4

8.3

398

2910

C71.60

ICD-10 Finland

Malignant tumor of cerebellum without histology

12.7

8.3

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.1

8.3

6053

56832

U01

ICPC

Dysuria/painful urination

1.3

8.3

790

6347

A03FA02

ATC

cisapride; oral, rectal

1.3

8.3

585

4528

S02CA02

ATC

flumetasone and antiinfectives; otic

1.4

8.3

432

3201

CEA00

NOMESCO Finland

Biopsy of extraocular muscle

+∞

8.3

N05AN01

ATC

lithium; oral

1.5

8.3

213

1384

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

1.5

8.3

217

1416

PAW37

NOMESCO Finland

Biopsy of temporal artery

2.4

8.3

231

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.4

8.3

339

2415

P80

ICPC

Personality disorder

2.4

8.3

225

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.2

8.3

1174

9839

N07XX09

ATC

[U] dimethyl fumarate

3.2

8.3

H36.01

ICD-10 Finland

Diabetic maculopathy

1.8

8.3

109

594

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.5

8.3

241

1610

SPAT1281

SPAT

Other administrative function

1.3

8.3

712

5657

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

1.5

8.2

263

1790

P07.2

ICD-10 Finland

Extreme immaturity

7.0

8.2

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

1.5

8.2

241

1614

K04.1

ICD-10 Finland

Necrosis of pulp

1.2

8.2

1073

8926

SPAT1304

SPAT

Counselling and guidance related to ageing

1.3

8.2

484

3659

R01AD12

ATC

fluticasone furoate; nasal

1.1

8.2

3530

32183

205

Kela drug reimbursment

Chronic hypertension

1.2

8.1

2028

17823

L14

ICPC

Leg/thigh symptom/complaint

1.3

8.1

754

6043

K04.09

ICD-10 Finland

Pulpit UNS

1.3

8.1

453

3395

H92.0

ICD-10 Finland

Otalgia

1.3

8.1

677

5358

F81.8

ICD-10 Finland

Other developmental disorders of scholastic skills

2.7

8.1

151

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.2

8.1

920

7542

H54.3

ICD-10 Finland

Mild or no visual impairment, binocular

3.0

8.1

113

7819X

ICD-9 Finland

Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]

2.1

8.1

336

K04.08

ICD-10 Finland

Other specified pulpit

1.2

8.1

811

6559

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.3

8.1

676

5352

E22.80

ICD-10 Finland

Central precocious puberty

4.7

8.1

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.2

8.1

1291

10942

3795A

ICD-9 Finland

Other disorders of eye, Nystagmus and other irregular eye movements

33.3

8.1

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

1.6

8.1

161

987

R96

ICPC

Asthma

1.2

8.0

934

7673

L18

ICPC

Muscle pain

1.4

8.0

403

2971

R03BA08

ATC

ciclesonide; inhalant

1.3

8.0

793

6401

L15

ICPC

Knee symptom/complaint

1.1

8.0

2573

23015

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

2.0

8.0

445

H47.3

ICD-10 Finland

Other disorders of optic disc

2.7

8.0

152

N06AA12

ATC

doxepin; systemic

1.4

8.0

377

2752

K10.3

ICD-10 Finland

Alveolitis of jaws

1.3

8.0

474

3585

AN1

Coronary angiography

1.3

8.0

745

5976

L04AA06

ATC

mycophenolic acid; systemic

1.6

8.0

172

1075

Q21.10

ICD-10 Finland

Persistent ostium secundum

2.2

7.9

299

SPAT1104

SPAT

Monitoring of emergency patient

1.3

7.9

537

4136

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.2

7.9

1261

10679

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.4

7.9

375

2739

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

1.6

7.9

164

1014

R05FA02

ATC

opium derivatives and expectorants; systemic

1.1

7.9

3927

36075

S02

ICPC

Pruritus

1.4

7.9

357

2587

R52.1

ICD-10 Finland

Chronic intractable pain

2.0

7.9

433

G03DC03

ATC

lynestrenol; oral

1.5

7.9

200

1296

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

1.7

7.9

141

839

G40.09

ICD-10 Finland

Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset

2.5

7.9

182

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

2.2

7.9

287

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

1.8

7.9

102

553

G40.89

ICD-10 Finland

Other epilepsy

2.4

7.9

200

K08.80

ICD-10 Finland

Toothache NOS

1.2

7.9

910

7472

F06.7

ICD-10 Finland

Mild cognitive disorder

1.5

7.9

199

1290

R06AX27

ATC

desloratadine; oral

1.1

7.9

3290

29921

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.1

7.9

3205

29105

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.2

7.8

1240

10497

H05.1

ICD-10 Finland

Chronic inflammatory disorders of orbit

7.7

7.8

I60.4

ICD-10 Finland

Subarachnoid haemorrhage from basilar artery

4.6

7.8

D32.03

ICD-10 Finland

Benign meningioma in ventricles

3.9

7.8

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

2.0

7.8

367

R29

ICPC

Respiratory symptom/complaint other

1.3

7.8

646

5107

N05BA06

ATC

lorazepam; systemic, sublingual

1.4

7.8

394

2908

SCA01

NOMESCO Finland

Preventive oral health care, short

1.1

7.8

3548

32426

A10BK03

ATC

empagliflozin; oral

1.2

7.8

815

6621

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.2

7.8

2037

17960

N19

ICPC

Speech disorder

1.7

7.8

135

798

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

1.6

7.8

166

1035

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

1.6

7.8

171

1074

PA7CG

NOMESCO Finland

Extended MRI examination of vessesl in brain and neck with high intensity magnet

4.0

7.7

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

1.6

7.7

155

951

D32.01

ICD-10 Finland

Benign tumor of meninges on interhemispheric surface

2.5

7.7

184

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.3

7.7

447

3369

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

1.5

7.7

214

1416

IGY02, ,

SPAT

1.6

7.7

162

1006

S09.9

ICD-10 Finland

Unspecified injury of head

1.7

7.7

138

823

3682A

ICD-9 Finland

Visual disturbances, Diplopia

15.0

7.7

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.3

7.7

539

4173

WZC00, ,

SPAT

1.2

7.7

1570

13585

XF600

NOMESCO Finland

Bloodpressure measurement

1.3

7.7

560

4358

H36.00

ICD-10 Finland

Diabetic background retinopathy

1.8

7.6

116

661

KH1AD

NOMESCO Finland

CT of urinary organs

1.4

7.6

291

2051

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

1.4

7.6

321

2302

V200A

ICD-9 Finland

Health supervision of infant or child, Foundling

3.2

7.6

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.3

7.6

620

4895

S01BA04

ATC

prednisolone; ophthalmic

1.6

7.6

155

956

PA2YT

NOMESCO Finland

Cerebral artery PTA with stent

3.3

7.6

Z61.8

ICD-10 Finland

Other negative life events in childhood

2.9

7.6

112

RF220, ,

NOMESCO Finland

1.8

7.6

109

611

G44.0

ICD-10 Finland

Cluster headache syndrome

1.8

7.6

105

582

H60.8

ICD-10 Finland

Other otitis externa

1.4

7.6

290

2044

SFA00

NOMESCO Finland

Small restoration

1.2

7.6

1374

11773

D01AE16

ATC

amorolfine; topical

1.2

7.6

937

7750

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.3

7.6

705

5655

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.2

7.5

1183

10009

G99.0*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic autonomic neuropathy

8.8

7.5

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

2.1

7.5

326

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.2

7.5

1604

13930

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

1.5

7.5

230

1556

M89.0

ICD-10 Finland

Algoneurodystrophy

2.0

7.5

415

H40.9

ICD-10 Finland

Glaucoma, unspecified

1.7

7.5

124

725

R41.0

ICD-10 Finland

Disorientation, unspecified

1.5

7.5

212

1411

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

1.7

7.4

119

688

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

1.6

7.4

160

1000

N06AG02

ATC

moclobemide; oral

1.4

7.4

331

2396

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

1.8

7.4

101

557

H65.2

ICD-10 Finland

Chronic serous otitis media

1.7

7.4

128

756

SPAT1283

SPAT

Restricted health certificate

1.1

7.4

2036

18010

193

Kela drug reimbursment

Rasagiline

2.4

7.4

200

F98.8

ICD-10 Finland

Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence

2.4

7.4

200

L84

ICPC

Back syndrome without radiat pain

1.3

7.4

434

3278

R31

ICD-10 Finland

Unspecified haematuria

1.2

7.4

775

6298

D64.9

ICD-10 Finland

Anaemia, unspecified

1.2

7.4

862

7085

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

2.5

7.4

182

3672A

ICD-9 Finland

Disorders of refraction and accommodation, Astigmatism

79.9

7.4

H3601, E103,

ICD-10 Finland

1.9

7.4

430

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

2.1

7.4

295

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

1.9

7.4

437

M01AE01

ATC

ibuprofen; systemic, rectal

1.1

7.4

11199

109063

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

1.4

7.4

335

2432

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

1.5

7.4

254

1756

R1250, ,

SPAT

1.4

7.4

295

2096

N05AE04

ATC

ziprasidone; systemic

2.1

7.4

315

R29.2

ICD-10 Finland

Abnormal reflex

3.9

7.4

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

2.1

7.4

302

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

1.5

7.4

214

1431

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.3

7.3

470

3595

NHL14

NOMESCO Finland

Shortening or lengthening of achilles tendon

2.2

7.3

283

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

1.4

7.3

346

2529

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

7.3

219

1473

I63.8

ICD-10 Finland

Other cerebral infarction

2.1

7.3

336

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.1

7.3

2446

21926

M01AX01

ATC

nabumetone; oral

1.4

7.3

303

2168

A11CC03

ATC

alfacalcidol; systemic

1.5

7.3

183

1186

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

1.7

7.3

115

663

IGV01

NOMESCO Finland

Psychiatric network contact

1.7

7.3

133

798

D06AX01

ATC

fusidic acid; topical

1.2

7.3

844

6935

2133

FHL

Suntin revisio

10.8

7.3

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.3

7.3

487

3749

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

1.4

7.3

270

1894

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

2.1

7.3

304

D32

ICD-10 Finland

Benign neoplasm of meninges

9.3

7.3

L73.2

ICD-10 Finland

Hidradenitis suppurativa

1.8

7.3

104

583

D01AE15

ATC

terbinafine; topical

1.3

7.2

556

4359

N07AA03

ATC

distigmine; systemic

3.1

7.2

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

478

623

7.89

307.65

1.1

2.40

9.93

nmol/l

1.75

121

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4732

33775

1.61

138.86

2.4

2.2

184.01

208.41

u/l

1.06

4499

32026

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

763

3185

2.47

112.05

1.5

511.99

507.12

mg/l

0.07

731

3047

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

675

2840

2.44

97.21

1.4

1.5

3.73

3.68

mmol/l

0.70

638

2694

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

659

2794

2.42

93.27

1.6

36.13

23.63

e6/l

0.32

504

2043

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

663

2836

2.40

91.98

1.6

1161.41

2479.18

e6/l

0.46

535

2213

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

6281

50563

1.45

91.92

8.7

6.9

1.21

mmol/l

2.04

5890

47059

(3013826) Glucose [Moles/volume] in Serum or Plasma

7997

67450

1.45

90.31

6.5

5.1

6.61

6.58

mmol/l

0.82

7613

63362

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

6891

56603

1.44

89.43

9.0

7.4

1.21

mmol/l

0.51

6014

49247

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

249

702

3.58

74.00

1.1

1.24

1.08

u/l

1.21

109

282

(3032080) INR in Blood by Coagulation assay

6014

49383

1.39

71.68

13.2

13.4

1.20

1.22

inr

3.16

5085

41154

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

320

1077

3.01

71.30

1.2

1.1

46.02

40.50

mg/l

0.48

259

908

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

311

1042

3.02

69.85

1.1

302.17

247.49

mg/l

0.83

268

930

(3024561) Albumin [Mass/volume] in Serum or Plasma

6125

50623

1.38

69.28

5.5

5.2

36.02

36.12

g/l

0.66

5787

47593

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

342

1229

2.82

67.66

1.1

1.0

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

5073

40804

1.38

67.08

4.1

3.6

36.70

70.90

ng/l

1.65

3341

25971

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

10250

92518

1.44

66.42

5.3

4.5

14.79

14.63

pmol/l

9.21

9568

85801

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

292

982

3.01

65.17

1.1

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

9697

87118

1.39

60.92

8.9

8.1

80.48

78.98

u/l

1.84

9249

82950

(3035350) Ketones [Presence] in Urine by Test strip

7392

63712

1.35

60.17

4.6

3.8

2.41

4.24

estimate

0.62

1592

13289

(3009261) Glucose [Presence] in Urine by Test strip

7426

64061

1.35

60.03

4.6

3.9

0.03

0.20

estimate

0.86

1527

12669

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2401

17257

1.47

58.29

2.5

2.4

29.33

29.58

1.20

2322

16791

(3021601) Nitrite [Presence] in Urine by Test strip

7302

63038

1.34

57.61

4.5

3.8

0.00

estimate

0.02

1571

13075

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

317

1195

2.68

57.23

1.8

1.5

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

247

815

3.06

57.02

1.3

1.2

0.63

0.65

ratio

0.23

130

481

(3018418) pH of Serum or Plasma

4216

33552

1.37

57.00

4.8

4.2

7.40

0.14

3120

23774

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

9565

86074

1.37

56.97

4.9

4.3

11.14

11.07

mm/h

0.18

9016

81101

(3029937) Albumin [Presence] in Urine by Test strip

4274

34255

1.36

54.67

4.9

4.0

0.00

estimate

0.11

1497

12204

(3031040) Bacteria [#/volume] in Urine by Automated count

8658

76971

1.34

54.14

5.7

4.6

1361.03

1746.52

e6/l

0.27

164

986

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

6924

59651

1.32

53.67

6.7

6.5

11.20

11.52

umol/l

1.05

6603

56743

(3001604) Monocytes [#/volume] in Blood

7131

61760

1.32

52.90

7.9

6.6

0.58

0.57

e9/l

0.65

6246

53281

(3006315) Basophils [#/volume] in Blood

7145

61899

1.32

52.89

7.9

6.6

0.04

e9/l

0.75

6260

53376

(3019977) pH of Arterial blood

1799

12418

1.51

52.82

9.9

8.2

7.42

0.42

1038

6663

(3003396) Base excess in Arterial blood by calculation

1785

12307

1.51

52.70

9.7

8.1

1.09

0.84

mmol/l

1.94

1468

10101

(3019550) Sodium [Moles/volume] in Serum or Plasma

12143

114537

1.58

52.49

21.7

17.0

139.67

139.64

mmol/l

0.74

11940

112327

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1754

12060

1.52

52.44

2.6

2.3

360.68

377.61

nmol/l

3.21

1642

11241

(3023368) Bacteria identified in Blood by Culture

3801

30089

1.36

52.08

4.7

4.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

666

3552

1.91

51.81

2.7

2.0

4.32

7.21

iu/l

0.59

306

1526

(3016502) Oxygen saturation in Arterial blood

1622

10998

1.53

51.70

10.1

8.5

95.94

95.72

0.80

1578

10606

(3023103) Potassium [Moles/volume] in Serum or Plasma

12157

114770

1.57

51.52

21.7

17.1

3.96

3.95

mmol/l

1.15

11927

112322

(3019198) Lymphocytes [#/volume] in Blood

7273

63305

1.32

51.34

7.9

6.7

1.95

e9/l

0.05

6511

55939

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1790

12425

1.50

51.03

9.8

8.1

5.12

5.08

kpa

1.00

1721

11968

(3027801) Oxygen [Partial pressure] in Arterial blood

1789

12420

1.50

50.96

9.8

8.1

12.67

12.75

kpa

0.23

1726

11958

(3037467) Urinalysis macro (dipstick) panel - Urine

8967

80433

1.33

50.86

5.3

4.5

1.68

6.67

—

113

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

11515

107567

1.46

50.54

6.4

5.4

1.83

1.86

mu/l

1.29

10890

100916

(3013115) Eosinophils [#/volume] in Blood

7314

63848

1.31

49.85

8.3

6.9

0.19

e9/l

0.21

6518

55997

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4497

36699

1.33

49.77

3.0

2.7

55.54

61.70

u/l

1.93

4162

34164

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2118

15312

1.45

48.94

7.3

6.6

1.07

1.06

mmol/l

0.49

1983

14302

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1515

10319

1.52

47.00

10.7

8.9

122.06

121.54

g/l

0.43

1485

10076

(3005719) IgG [Mass/volume] in Serum or Plasma

1453

9827

1.53

46.56

3.0

2.9

10.27

10.44

g/l

0.89

1338

9124

(3015736) pH of Urine

5980

51089

1.30

46.50

4.0

3.4

6.30

6.23

5.71

3379

28606

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

259

985

2.65

46.00

1.4

1.2

1.95

1.99

mmol/l

0.25

235

925

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

5620

47770

1.30

44.83

4.5

3.7

0.39

0.30

estimate

0.09

1307

10814

(3007853) Bacteria identified in Skin by Aerobe culture

1951

14174

1.44

43.41

2.0

1.8

—

(3019309) Folate [Moles/volume] in Red Blood Cells

2324

17473

1.39

42.42

1.8

1.7

1211.29

1165.84

nmol/l

1.49

1803

13430

(3000850) Epithelial cells [#/volume] in Urine

3254

25809

1.34

42.25

3.2

2.8

5.96

6.05

e6/l

0.13

2987

23424

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

12150

115457

1.50

41.46

18.6

14.9

22.11

23.16

mg/l

3.08

10171

94123

(3013650) Neutrophils [#/volume] in Blood by Automated count

7719

68703

1.28

41.45

11.3

9.8

4.14

4.06

e9/l

2.01

6796

59609

(3015377) Calcium [Moles/volume] in Serum or Plasma

4652

39011

1.29

39.66

3.2

3.4

2.35

2.36

mmol/l

1.24

4233

35706

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1856

13573

1.42

39.49

1.9

1.8

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1000

6444

1.59

39.43

9.0

6.8

24.68

24.46

mmol/l

1.07

961

6161

(3019150) Specific gravity of Urine by Refractometry

3507

28383

1.31

38.92

4.8

3.9

1.02

1.24

kg/l

1.34

2370

18612

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2409

18503

1.36

38.07

2.1

1.9

—

(3006504) Eosinophils/Leukocytes in Blood

6480

56786

1.27

38.01

8.0

6.8

2.81

2.85

0.74

6140

53477

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1261

8627

1.50

37.87

2.5

2.4

19.91

20.01

au/ml

0.02

119

1034

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1185

8006

1.52

37.78

1.3

52.64

50.20

au/ml

0.14

502

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2464

19025

1.36

37.58

4.3

3.9

0.82

mmol/l

0.15

2322

18002

(3019069) Monocytes/Leukocytes in Blood

6488

56927

1.26

37.42

8.2

6.9

8.70

8.69

0.14

6153

53635

(3022096) Basophils/Leukocytes in Blood

6465

56737

1.26

37.08

8.1

6.9

0.67

0.68

0.48

6120

53355

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3658

29948

1.30

36.87

3.4

3.2

1176.62

1273.91

ng/l

0.59

3100

25529

(3002030) Lymphocytes/Leukocytes in Blood

6645

58580

1.26

36.37

8.0

6.8

28.45

28.73

1.29

6338

55754

(3044889) 12 lead EKG panel

8510

77236

1.27

36.23

4.2

3.8

100.67

3204.50

0.69

135

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1747

12827

1.41

36.08

2.0

1.8

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

6191

54183

1.26

35.88

2.8

2.5

76.01

1718.85

nmol/l

0.50

5707

49907

(3021960) Folate [Moles/volume] in Serum or Plasma

3809

31527

1.29

34.86

1.7

20.25

20.06

nmol/l

0.30

3306

27149

(3009466) Valproate [Moles/volume] in Serum or Plasma

345

1691

2.06

34.16

5.4

5.6

387.12

369.02

umol/l

1.18

309

1487

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2864

22910

1.31

33.76

1.7

38436665.29

29563414.81

pmol/l

0.32

2430

19450

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

5645

49110

1.25

33.67

2.2

2.1

97.07

96.81

pmol/l

0.15

3022

26426

(3014576) Chloride [Moles/volume] in Serum or Plasma

1984

15041

1.37

33.61

9.2

7.7

104.49

104.43

mmol/l

0.23

1984

15034

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4725

40339

1.26

33.03

3.7

3.4

31.95

33.29

u/l

0.77

4484

38163

(3018010) Neutrophils/Leukocytes in Blood

6496

57558

1.24

32.35

7.8

6.7

56.80

56.56

0.94

6269

55179

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

132

426

3.11

31.84

1.2

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

786

5040

1.59

31.50

2.0

38.87

39.85

u/l

0.67

717

4551

(3026782) Osmolality of Urine

2742

22008

1.30

31.16

3.2

2.9

528.62

536.07

mosm/kgh2o

0.94

2407

19301

(3002582) Erythrocytes [#/volume] in Urine

4427

37740

1.25

30.73

4.0

3.4

66.21

75.51

e6/l

0.24

3508

28495

(3023410) Appearance of Cerebral spinal fluid

283

1352

2.11

30.04

1.8

2.0

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

12567

121202

1.50

29.80

22.8

18.6

75.03

74.58

umol/l

0.80

12464

119865

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1620

12117

1.38

29.55

7.7

6.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3207

26425

1.28

29.44

2.0

1.9

1.18

1.16

mg/l

0.08

2459

20212

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1152

8201

1.44

27.89

4.0

3.4

4.52

4.55

pmol/l

0.49

1059

7410

(3009508) Creatinine [Moles/volume] in Urine

4493

38669

1.24

27.88

3.8

3.5

7.65

7.76

mmol/l

0.84

3866

33290

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3703

31257

1.25

27.28

2.6

2.4

2.75

2.72

mg/l

0.34

3264

27217

(3030467) Casts [#/volume] in Urine by Automated count

3848

32688

1.24

26.64

3.8

3.3

0.38

e6/l

0.04

2940

23645

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

11265

107116

1.30

26.09

5.3

4.7

5.91

5.83

mmol/l

8.03

10492

99683

(3014111) Lactate [Moles/volume] in Serum or Plasma

1373

10200

1.38

25.92

10.2

8.4

1.31

1.33

mmol/l

0.26

1341

10009

(3037522) Nuclear Ab [Titer] in Serum

2235

17849

1.30

25.76

1.4

460.38

526.37

titre

1.08

469

3715

(36304419) Bacteria [Presence] in Urine

3695

31389

1.24

25.29

3.7

3.2

2845.21

128.53

estimate

0.47

122

(3011397) Hemoglobin [Presence] in Urine by Test strip

3449

29132

1.24

24.78

4.4

3.7

0.35

0.37

0.04

254

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1184

8652

1.40

24.63

4.5

4.2

85.06

85.50

ng/l

0.05

1044

7574

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

159

649

2.46

24.60

1.8

1.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3671

31285

1.23

24.15

1.4

1.24

1.81

u/ml

3.00

1059

8564

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

262

1323

1.99

24.01

3.6

2.9

20.33

21.09

nmol/l

0.42

253

1268

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

165

693

2.39

24.00

1.2

1.1

—

(3018095) Leukocytes [#/volume] in Urine

5012

44127

1.21

23.77

4.7

4.0

89.34

87.68

e6/l

0.04

3646

30379

(3021589) Normoblasts [#/volume] in Blood

5993

53679

1.20

23.67

13.1

11.2

0.00

e9/l

0.18

4954

43581

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1159

8504

1.39

23.50

12.5

9.5

24.92

24.73

mmol/l

1.10

1150

8461

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

132

504

2.63

23.49

1.1

350.34

184.99

ng/l

0.34

122

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

6163

55388

1.20

23.35

3.0

2.8

—

estimate

—

(3020891) Body temperature

734

4955

1.50

23.25

5.9

4.6

36.91

36.92

°c

0.51

727

4910

(40760892) CBC W Ordered Manual Differential panel - Blood

3323

28134

1.24

23.04

5.7

4.6

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

599

3893

1.56

22.61

2.4

2.3

673.32

495.81

ug/l

0.22

549

3677

(3023183) Ammonium ion [Moles/volume] in Plasma

419

2496

1.70

22.52

2.6

2.9

32.32

34.16

umol/l

0.80

384

2267

(3001122) Ferritin [Mass/volume] in Serum or Plasma

6734

61149

1.20

22.38

3.6

3.2

105.91

108.64

ug/l

0.38

6346

57701

(3018405) Lactate [Moles/volume] in Arterial blood

531

3372

1.59

22.16

5.1

4.0

1.29

1.40

mmol/l

1.92

521

3311

(3042936) Bacteria identified in Isolate by Culture

2028

16291

1.28

22.00

2.3

2.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

10971

104499

1.25

21.65

6.7

5.8

39.24

38.51

mmol/mol

12.94

10351

98795

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

883

6267

1.43

21.61

12.6

10.4

16.10

16.05

0.24

852

6043

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2746

22922

1.24

21.45

1.4

1.3

27.70

30.54

iu/ml

0.43

784

6749

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

151

642

2.36

21.42

1.2

1.1

—

(3022948) Iron [Moles/volume] in Serum or Plasma

2434

20051

1.26

21.36

2.9

2.6

13.18

13.43

umol/l

0.94

2273

18789

(3020779) Urea [Moles/volume] in Serum or Plasma

1342

10231

1.34

21.28

9.1

8.3

8.74

9.10

mmol/l

1.24

1285

9824

(3012516) Albumin [Mass/volume] in Urine

3897

33765

1.21

21.16

3.7

3.6

52.31

51.13

mg/l

0.11

2579

21657

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

12446

120614

1.38

20.85

13.6

11.5

26.34

26.33

u/l

0.01

12170

117586

(3041096) Erythrocytes [Presence] in Urine by Automated

4008

34890

1.21

20.60

3.8

3.2

0.20

0.15

estimate

0.10

1323

10536

(3033658) Prothrombin time (PT) actual/Normal

3457

29691

1.22

20.37

4.8

4.3

91.00

90.92

0.06

3370

29028

(3000991) Gas panel - Venous blood

1366

10510

1.33

20.30

11.8

9.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

237

3.25

20.25

1.2

1.3

—

(3012544) pH of Venous blood

1544

12102

1.31

20.08

5.8

4.7

7.38

0.15

959

7068

(3020682) Albumin/Creatinine [Ratio] in Urine

3939

34318

1.20

19.91

4.5

4.2

10.00

8.87

mg/mmol

0.64

2545

21597

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1117

8372

1.36

19.76

2.4

2.3

6.56

7.34

ug/l

0.50

961

7325

(3002032) Base excess in Venous blood by calculation

1490

11658

1.31

19.61

5.9

4.8

1.79

1.71

mmol/l

0.45

1318

10118

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1523

11966

1.30

19.42

5.9

4.7

5.86

5.82

kpa

0.88

1490

11672

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

890

6456

1.40

19.23

12.0

10.4

24.41

24.22

mmol/l

1.04

866

6337

(3007164) IgA [Mass/volume] in Serum or Plasma

3194

27357

1.22

19.14

1.6

1.5

2.26

2.28

g/l

0.21

2054

17202

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

142

623

2.29

18.80

1.6

1.2

57.19

70.88

0.85

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2249

18633

1.24

18.47

2.9

2.6

2.38

2.37

g/l

0.54

2084

17302

(3024354) Oxygen [Partial pressure] in Venous blood

1306

10119

1.32

18.40

5.5

4.3

4.71

4.65

kpa

0.50

1271

9860

(40758558) Short blood count panel - Blood

4066

35780

1.19

17.98

7.1

6.5

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1166

8923

1.33

17.91

2.5

2.6

66.53

66.51

g/l

0.04

1085

8226

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2510

21107

1.23

17.87

4.2

3.8

293.72

460.13

ng/l

1.34

1842

15291

(40768797) Stomach Pathology biopsy report

1924

15720

1.26

17.82

1.3

1.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2511

21129

1.23

17.75

1.3

9.42

10.42

u/ml

0.30

1010

8520

(3013512) EKG study

4082

36019

1.19

17.34

3.7

3.5

0.67

0.76

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

675

4748

1.44

17.34

6.9

4.9

1.70

1.65

0.65

643

4485

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

169

826

2.05

17.10

21.4

21.1

1499.71

2551.18

nmol/l

0.44

162

799

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

11200

107545

1.23

16.88

16.7

14.1

85.48

85.42

ml/min/173m2

0.10

10336

98213

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

8705

81788

1.17

16.56

3.8

3.3

46.87

43.53

u/l

1.87

8259

77554

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

949

7141

1.35

16.30

5.9

4.6

1.52

1.53

mmol/l

0.03

690

5233

(3007930) Methemoglobin/Hemoglobin.total in Blood

621

4352

1.44

16.28

7.2

5.1

0.89

0.88

0.19

594

4105

(3017732) Neutrophils [#/volume] in Blood

1850

15217

1.25

16.02

3.3

3.1

4.45

e9/l

0.01

1612

13351

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

318

2.68

15.90

1.0

1.1

—

(3009343) pH of Capillary blood

1046

8014

1.33

15.90

6.0

4.6

7.41

0.10

886

6630

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1069

8217

1.32

15.88

5.9

4.6

5.14

5.12

kpa

0.45

1030

7887

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2054

17103

1.23

15.87

3.0

2.7

22.23

22.80

1.16

1911

15982

(3023520) Reticulocytes [#/volume] in Blood

1238

9711

1.30

15.85

2.8

68.95

69.57

e9/l

0.25

906

6990

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1356

10769

1.28

15.78

3.8

3.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1074

8273

1.32

15.71

1.8

1.7

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1009

7704

1.33

15.70

2.0

1.9

1.27

1.31

g/l

0.32

951

7136

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

327

2.63

15.59

1.1

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

10367

99008

1.19

15.53

22.7

18.2

13.56

13.50

5.13

10255

97759

(3027945) Reticulocytes/Erythrocytes in Blood

1575

12764

1.26

15.50

3.3

2.9

1.74

1.75

0.11

1423

11465

(3047181) Lactate [Moles/volume] in Blood

481

3241

1.50

15.43

7.6

5.5

1.27

1.29

mmol/l

0.14

422

2860

(3017181) Myelocytes/Leukocytes in Blood

1319

10497

1.28

15.07

5.0

4.6

0.86

0.91

0.30

391

3107

(3007461) Platelets [#/volume] in Blood

12890

126250

1.41

14.65

28.6

22.7

256.22

255.95

e9/l

0.17

12693

123860

(3035941) MCH [Entitic mass]

12892

126293

1.41

14.43

28.5

22.5

30.14

30.18

2.15

12796

125184

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

12893

126305

1.41

14.43

29.3

23.1

40.69

40.93

0.31

12795

125137

(3026361) Erythrocytes [#/volume] in Blood

12893

126309

1.41

14.39

28.5

22.6

4.51

e12/l

0.08

12665

123579

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

228

2.90

14.38

3.5

2.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

118

538

2.20

14.37

1.1

—

0.13

—

(3010813) Leukocytes [#/volume] in Blood

12895

126334

1.41

14.36

28.6

22.7

6.82

6.73

e9/l

3.62

12665

123574

(3024731) MCV [Entitic mean volume] in Red Blood Cells

12891

126289

1.41

14.35

28.5

22.5

90.45

90.54

1.47

12795

125177

(3000963) Hemoglobin [Mass/volume] in Blood

12895

126335

1.41

14.35

28.8

22.8

135.07

135.36

g/l

1.54

12797

125250

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

666

4844

1.39

14.17

6.7

5.1

24.66

24.56

mmol/l

0.46

622

4555

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

720

5306

1.37

14.14

5.0

4.2

50.56

48.32

1.60

710

5227

(3039000) Anion gap in Blood by calculation

339

2162

1.58

14.02

9.5

6.7

11.28

11.31

mmol/l

0.06

312

1931

(3023420) DNA double strand Ab [Units/volume] in Serum

714

5263

1.37

14.00

1.8

1.9

7.05

6.83

iu/ml

0.08

174

1263

(3018572) Chloride [Moles/volume] in Blood

339

2163

1.58

13.99

9.5

6.7

105.35

105.09

mmol/l

0.44

312

1933

(3002179) Metamyelocytes/Leukocytes in Blood

1256

10027

1.27

13.96

4.6

4.5

0.67

0.01

363

2980

(3044640) Blood type and Crossmatch panel - Blood

4259

38218

1.16

13.95

2.7

2.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

329

2.52

13.88

1.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

3349

29506

1.18

13.83

2.8

2.7

333.34

334.65

umol/l

0.31

2983

26378

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

5199

47392

1.15

13.67

2.0

1.9

1.35

1.36

mmol/l

0.37

4472

40591

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

451

3086

1.47

13.45

1.7

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

775

5828

1.35

13.37

5.1

3.7

1.33

1.28

0.59

766

5799

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

462

3181

1.46

13.34

2.2

2.1

11.24

11.30

mg/l

0.05

436

2987

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1380

11208

1.25

13.25

2.5

0.21

g/l

0.10

1290

10494

(3010838) Calcium [Moles/time] in 24 hour Urine

315

2005

1.58

13.17

2.0

1.9

5.24

5.05

mmol/24h

0.46

294

1793

(3022313) Gas panel - Capillary blood

770

5802

1.34

13.11

6.5

4.9

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

551

3936

1.41

13.04

1.7

1.8

0.23

g/l

0.35

517

3771

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2387

20526

1.19

13.00

3.4

3.0

1.05

1.25

e6/l

0.65

1334

10746

(3045414) Leukocytes [Presence] in Urine

1379

11229

1.25

12.93

2.2

2.1

0.03

estimate

0.01

297

2433

(40761536) Microorganisms panel - Urine sediment

1198

9598

1.27

12.91

4.7

3.9

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

152

794

1.92

12.86

17.0

15.2

878.19

2441.85

nmol/l

0.47

145

770

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

573

4134

1.40

12.81

2.5

1.9

2.69

2.20

ug/l

0.37

496

3674

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

764

5771

1.34

12.80

5.1

3.6

0.64

0.62

0.76

758

5750

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

563

4053

1.40

12.75

1.7

1.8

1.20

1.19

g/l

0.68

532

3895

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2499

21610

1.19

12.74

2.8

2.9

2.44

mmol/l

1.50

2222

19318

(3025159) Blasts/Leukocytes in Blood

1266

10231

1.26

12.67

5.3

4.8

0.29

0.25

0.05

313

2584

(3027273) Bicarbonate [Moles/volume] in Venous blood

646

4767

1.37

12.60

4.5

3.7

25.29

25.15

mmol/l

0.48

624

4605

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

301

2.49

12.28

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

343

2.39

12.28

2.7

2.2

18.38

15.98

umol/l

0.95

343

(3005322) IgE [Units/volume] in Serum or Plasma

1119

8949

1.27

12.23

1.4

1.3

206.48

244.10

u/ml

0.62

1043

8334

(3004119) Hemoglobin [Mass/volume] in Venous blood

879

6821

1.30

12.17

5.4

3.9

129.91

129.99

g/l

0.04

852

6637

(3010421) pH of Blood

495

3514

1.42

12.16

4.7

3.7

7.41

0.10

487

3475

(3021440) Promyelocytes/Leukocytes in Blood

1242

10075

1.25

12.02

5.1

4.7

0.12

0.11

0.15

315

2697

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1097

8774

1.27

11.98

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

431

2994

1.45

11.93

1.6

1.7

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

664

4976

1.35

11.74

1.3

0.93

1.03

u/ml

0.08

401

(3020961) Endomysium IgA Ab [Titer] in Serum

874

6811

1.30

11.73

1.1

1.2

141.67

200.43

titre

0.38

214

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

303

2.44

11.63

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

133

689

1.93

11.58

2.0

1.7

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

880

6884

1.29

11.47

1.2

1.1

24.35

7.46

u/ml

0.35

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1144

9251

1.25

11.37

3.0

2.5

0.36

0.42

e6/l

0.52

1107

8817

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

390

2684

1.46

11.35

1.5

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

212

1271

1.67

11.35

1.5

1.7

—

(3048689) Calprotectin [Mass/mass] in Stool

2066

17747

1.19

11.24

2.6

139.18

125.38

ug/g

0.67

1627

14153

(3008295) Osmolality of Serum or Plasma

216

1305

1.66

11.23

1.7

1.5

282.73

280.68

mosm/kgh2o

0.62

172

993

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1534

12833

1.22

11.08

4.5

4.6

246.90

240.84

u/l

0.49

1453

12203

(3028626) Oxygen [Partial pressure] in Capillary blood

529

3876

1.38

10.83

7.7

5.2

8.95

8.79

kpa

1.30

519

3780

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

279

2.44

10.68

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

399

2.18

10.57

1.4

1.2

25.27

19.65

0.26

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

150

3.00

10.54

1.2

1.1

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

653

4962

1.33

10.54

1.8

1.6

23.10

13.19

iu/ml

0.46

145

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

950

7593

1.27

10.43

6.4

5.1

24.21

24.11

mmol/l

0.55

938

7524

(3011412) CD3 cells [#/volume] in Blood

217

1340

1.62

10.39

3.0

2.7

1239.35

1275.36

e6/l

0.29

190

1127

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

571

4268

1.35

10.31

1.6

3.78

7.05

iu/ml

0.24

797

(3013005) Retinol [Moles/volume] in Serum or Plasma

133

720

1.85

10.19

2.2

2.4

1.90

1.84

umol/l

0.36

123

671

(44790049) Parainfluenza type 3 nucleic acid detection

247

1583

1.57

10.13

1.6

—

(44790048) Parainfluenza type 2 nucleic acid detection

247

1583

1.57

10.13

1.6

—

(44806118) Parainfluenza type 4 nucleic acid detection

247

1583

1.57

10.13

1.6

—

(44790047) Parainfluenza type 1 nucleic acid detection

247

1583

1.57

10.13

1.6

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

522

3873

1.36

9.90

1.2

1.3

21.69

36.84

u/ml

1.20

219

(3028707) Methadone [Presence] in Urine by Screen method

430

3092

1.40

9.89

3.0

2.8

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

247

2.47

9.88

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

442

3195

1.39

9.85

1.9

1.7

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

135

3.03

9.83

1.2

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

11452

111264

1.17

9.80

5.2

4.8

4.56

4.66

mmol/l

23.37

10823

105274

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1067

8710

1.24

9.74

4.6

3.9

1.23

mmol/l

0.67

924

7555

(3021387) Prolactin [Units/volume] in Serum or Plasma

744

5823

1.29

9.69

1.9

1.7

341.27

307.36

mu/l

1.38

671

5275

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

11565

112484

1.18

9.61

5.8

5.3

2.67

2.75

mmol/l

15.87

10899

105990

(3011288) Drugs identified in Urine by Screen method Nominal

665

5148

1.30

9.42

3.4

2.9

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

300

2038

1.48

9.41

1.3

1.2

272.04

332.41

titre

0.18

160

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

11385

110633

1.17

9.38

5.1

4.7

1.44

1.46

mmol/l

10.30

10704

104158

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

302

2059

1.47

9.31

1.3

1.2

354.55

127.69

titre

0.46

(3000494) Fungus identified in Specimen by Culture

1682

14418

1.19

9.27

1.6

1.5

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

108

565

1.91

9.24

2.8

2.6

57.20

51.73

umol/l

1.00

511

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

117

630

1.86

9.17

3.3

2.4

122.57

158.18

umol/l

0.87

323

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

115

3.13

9.11

1.0

1.1

—

(36660697) Celiac disease serology panel - Serum

1326

11158

1.21

8.97

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

483

3604

1.35

8.87

1.3

7.76

9.19

u/ml

0.23

518

(3014148) Varicella zoster virus Ab [Titer] in Serum

301

2072

1.46

8.85

1.2

—

(3027315) Oxygen [Partial pressure] in Blood

330

2312

1.43

8.84

5.4

4.0

8.82

8.75

kpa

0.30

322

2269

(3012501) Base excess in Blood by calculation

328

2296

1.44

8.82

5.5

4.0

2.53

2.40

mmol/l

0.33

227

1519

(3018133) Calcium [Moles/volume] in Urine

376

2.10

8.81

2.3

2.8

2.69

2.59

mmol/l

0.16

347

(3013290) Carbon dioxide [Partial pressure] in Blood

328

2297

1.43

8.81

5.5

4.0

5.06

5.00

kpa

0.78

320

2255

(1175426) CD3 cells/Lymphocytes in Blood

182

1124

1.62

8.79

2.9

2.4

73.95

72.30

0.68

175

1083

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

256

1712

1.50

8.71

1.4

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

174

1066

1.64

8.68

3.0

2.5

—

(3036489) Thrombin time

623

4836

1.30

8.67

2.8

2.6

20.93

20.92

0.02

553

4261

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

482

3610

1.34

8.64

1.3

3.57

6.62

u/ml

0.86

327

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

10840

105103

1.14

8.60

4.3

4.0

1.29

1.27

mmol/l

2.01

10128

98193

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

166

1008

1.65

8.58

2.8

444.10

530.89

e6/l

2.33

132

780

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

322

2259

1.43

8.57

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

184

1148

1.61

8.54

1.5

1.8

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

473

3540

1.34

8.53

1.5

1.4

277.14

280.29

ug/g

0.12

270

2009

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1620

13939

1.18

8.51

3.0

7.62

7.95

umol/l

0.25

1388

12099

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1159

9679

1.21

8.48

1.3

1.2

135.85

139.11

u/ml

0.10

445

3653

(3017143) Hepatitis C virus Ab [Presence] in Serum

1906

16627

1.17

8.44

1.7

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

556

4266

1.31

8.44

1.4

1.3

—

(3003181) Sodium [Moles/volume] in Urine

291

2015

1.45

8.33

1.5

72.65

63.10

mmol/l

2.57

229

1624

(3010015) Selenium [Moles/volume] in Serum or Plasma

183

2.57

8.32

2.7

2.2

1.20

1.26

umol/l

0.62

142

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

138

2.82

8.29

1.0

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

337

4643

0.72

8.26

1.5

1.25

1.19

ratio

0.51

203

2812

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

337

4643

0.72

8.26

1.5

0.95

ratio

0.09

202

2797

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

336

4626

0.72

8.20

1.5

1.22

1.15

ratio

0.62

201

2780

(1616796) Gas panel - Central venous blood

349

2510

1.40

8.10

4.6

3.8

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

168

1040

1.62

8.08

3.0

2.9

223.77

224.93

e6/l

0.02

144

839

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

531

4076

1.31

8.05

7.9

6.2

1.42

1.40

mg/l

0.18

485

3795

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1272

14866

0.84

8.05

1.8

1.9

3.48

3.46

ratio

0.18

940

11098

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

229

1524

1.51

8.01

8.1

6.6

11.63

11.49

mg/l

0.17

217

1418

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

447

3350

1.34

8.01

1.4

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

3848

35300

1.12

7.97

3.2

2.9

0.04

0.06

0.24

681

(3045424) Erythrocytes [Presence] in Urine

719

5745

1.26

7.96

2.2

2.1

0.02

0.15

estimate

0.51

238

1930

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

125

2.88

7.94

1.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3208

29124

1.13

7.91

2.7

2.4

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

524

4028

1.31

7.87

3.8

3.3

3.45

3.51

g/l

0.51

504

3841

(3015235) Bicarbonate [Moles/volume] in Capillary blood

509

3900

1.31

7.83

4.1

3.3

24.41

24.63

mmol/l

0.65

497

3840

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

332

4544

0.72

7.83

1.4

1.5

—

(3049233) Organic acids panel - Urine

3.92

7.83

1.4

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

400

2965

1.36

7.72

1.2

1.3

45.10

45.00

u/ml

0.00

271

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

287

2015

1.43

7.66

1.6

1.8

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.52

7.36

1.0

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

273

3811

0.71

7.28

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

862

7104

1.22

7.22

2.7

2.4

4304.71

6340.00

u/l

1.53

328

2776

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

269

1890

1.43

7.18

1.5

1.4

12.50

13.92

u/ml

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

311

2245

1.39

7.11

1.6

0.75

g/l

0.00

237

1760

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

260

1826

1.43

6.97

1.9

1.7

419.75

373.88

mu/l

0.70

206

1472

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

489

1.84

6.97

2.7

2.5

154.01

150.41

nmol/l

0.16

434

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

371

4901

0.75

6.97

1.5

62.38

61.99

ug/l

0.05

303

4147

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

135

2.66

6.92

1.2

1.4

57.70

58.60

0.04

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

398

3000

1.33

6.92

1.2

1.3

4.34

3.52

u/ml

0.13

194

(3024666) Lithium [Moles/volume] in Serum or Plasma

135

827

1.63

6.84

12.9

13.5

0.62

0.60

mmol/l

0.36

129

759

(3043238) Trisomy 21 risk [Likelihood] in Fetus

283

3882

0.72

6.82

1.5

1.6

—

(3005033) Fetal Nuchal fold Thickness US

269

3720

0.72

6.81

1.5

1.27

1.26

0.07

191

2749

(3026389) Candida sp identified in Specimen by Organism specific culture

268

1903

1.41

6.77

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

965

8096

1.20

6.75

3.5

3.0

170.81

176.86

ng/l

0.18

866

7343

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

137

2.62

6.74

1.2

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

961

8068

1.20

6.68

1.6

1.4

25.00

25.01

iu/l

0.00

780

6796

(3032352) Blasts [#/volume] in Cerebral spinal fluid

150

2.53

6.62

2.9

3.6

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

532

4197

1.27

6.60

3.7

3.2

95.17

93.86

0.64

507

4059

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

443

3415

1.30

6.58

3.0

3.3

34.57

47.14

mg/l

1.63

369

2896

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

220

1516

1.45

6.56

1.6

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

595

4766

1.26

6.51

1.7

1.5

9.35

9.68

u/l

0.23

471

3727

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

954

11219

0.84

6.46

1.5

1.6

3.44

3.46

mmol/l

0.16

626

7484

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

3.00

6.44

5.6

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

442

3418

1.30

6.43

3.1

3.3

46.32

67.08

mg/l

0.69

367

2897

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

240

2.16

6.39

2.2

1.6

1.64

1.00

nmol/l

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2109

18885

1.13

6.35

3.6

3.1

3.28

2.96

e6/l

0.56

1046

9058

(21494755) Public health laboratory ask at order entry panel

1106

12822

0.85

6.34

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

235

2.17

6.30

1.7

1.6

—

(3028271) Lactate [Moles/volume] in Capillary blood

247

1756

1.41

6.23

2.3

1.9

1.64

1.69

mmol/l

0.38

240

1718

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

798

6631

1.21

6.19

1.8

1.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

451

3516

1.29

6.18

2.7

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

108

643

1.68

6.16

2.2

2.5

28.03

27.63

umol/l

0.18

101

611

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

380

1.89

6.15

3.5

2.9

29.60

28.46

umol/l

0.32

281

(3037756) Immunofixation for Serum or Plasma

283

2065

1.37

6.13

1.6

1.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

299

2202

1.36

6.11

1.5

1.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1803

16019

1.14

6.11

2.0

1.8

1.44

1.42

0.41

1606

14227

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

2.90

6.10

5.8

5.7

120937.50

474335.68

u/ml

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

120

739

1.62

6.02

1.3

1.6

5.05

5.73

u/l

1.24

645

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.87

5.99

1.0

1.1

—

(3025941) Bacteria identified in Stool by Culture

823

6882

1.20

5.99

1.3

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

314

2340

1.35

5.96

2.9

2.6

16.81

16.65

0.44

306

2297

(3022145) Colonoscopy Study observation

1501

13195

1.15

5.93

1.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

681

5600

1.22

5.88

1.8

1.7

0.26

0.30

mg/l

1.28

301

2582

(4198724) Urine methamphetamine measurement

122

759

1.61

5.88

2.0

2.6

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

101

2.77

5.84

1.0

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

612

4982

1.24

5.83

1.9

1.8

1.51

1.49

g/l

0.16

531

4318

(3020717) Zinc [Moles/volume] in Serum or Plasma

132

839

1.57

5.82

1.8

1.6

21.22

22.14

umol/l

0.14

126

778

(3014765) Yersinia sp identified in Stool by Organism specific culture

419

3271

1.29

5.71

1.2

—

(3006245) CD3-CD19+ cells/cells in Blood

114

703

1.62

5.71

3.0

2.9

10.95

11.80

0.27

105

671

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

417

3254

1.29

5.70

1.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

201

1404

1.43

5.64

1.6

1.4

6.36

6.57

g/l

0.43

140

1020

(3023419) Bacteria identified in Sputum by Culture

191

1322

1.45

5.63

2.6

2.8

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

124

785

1.58

5.58

1.1

1543.47

1519.38

miu/ml

0.08

124

785

(3007566) Smooth muscle Ab [Titer] in Serum

460

3649

1.27

5.52

1.2

1.3

120.51

120.25

titre

0.00

365

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

546

4419

1.24

5.50

1.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

419

3288

1.28

5.50

1.2

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

200

1404

1.43

5.48

1.7

1.4

2.97

2.85

g/l

0.41

141

1019

(3024139) IgG subclass 3 [Mass/volume] in Serum

200

1404

1.43

5.48

1.7

1.4

0.39

g/l

0.02

140

1012

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

426

3359

1.27

5.39

4.7

4.2

0.36

0.34

iu/ml

0.70

223

1817

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

301

2267

1.33

5.36

1.6

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

472

1.74

5.34

1.1

—

(4062490) Immunoglobulin typing, IgG

196

1378

1.42

5.34

1.7

1.4

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

137

899

1.52

5.29

2.8

0.73

0.74

e9/l

0.12

127

869

(3021901) Oxygen saturation in Capillary blood

307

2330

1.32

5.20

3.8

3.3

91.28

90.50

1.33

301

2277

(3023511) Choriogonadotropin [Units/volume] in Urine

443

3526

1.26

5.20

1.4

—

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

3.12

5.15

1.3

1.5

32.47

32.90

0.02

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

215

1547

1.39

5.14

1.7

1.6

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

354

1.83

5.11

1.4

1.3

201.55

119.93

nmol/l

0.95

260

(3019225) pH of Specimen

1154

10066

1.16

5.09

4.5

4.2

7.36

0.62

836

7250

(3028433) Virus identified in Specimen by Culture

399

1.78

5.05

1.3

1.2

—

(3034770) Mitochondria Ab [Titer] in Serum

447

3578

1.25

5.01

1.2

1.3

1240.00

977.12

titre

0.22

111

(40757494) Bilirubin.total [Moles/volume] in Blood

575

1.63

4.92

1.9

2.6

70.44

65.95

umol/l

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

200

2.10

4.86

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

572

1.63

4.78

2.9

2.7

0.18

0.32

e9/l

1.85

290

(3037121) Protein [Mass/volume] in Urine

496

4044

1.23

4.73

3.7

3.8

287.63

393.94

mg/l

1.89

251

1944

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

648

5425

1.20

4.72

2.4

—

(3042517) Benzodiazepines panel - Urine

196

2.09

4.71

3.2

2.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1245

10982

1.14

4.70

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

322

2497

1.29

4.70

1.6

1.7

—

(3013336) Amino acids [Identifier] in Serum or Plasma

102

2.54

4.67

2.1

2.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1111

9728

1.15

4.67

2.5

2.3

12.20

12.52

nmol/l

0.62

998

8832

(3008898) HLA-B27 [Presence]

591

4914

1.21

4.64

1.1

—

(3035933) Granulocytes/Leukocytes in Blood

358

2819

1.27

4.64

3.4

3.3

58.27

57.51

0.54

358

2819

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

447

3612

1.24

4.64

1.1

2.23

6.84

eliau/ml

4.43

486

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

477

3884

1.23

4.61

3.3

3.1

183.40

184.95

0.15

454

3710

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

175

1242

1.41

4.58

1.5

1.4

8.20

8.11

mmol/l

0.10

166

1197

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

346

2721

1.27

4.54

6.5

6.2

793.67

1687.63

iu/ml

0.49

367

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.96

4.52

7.8

8.7

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

120

795

1.51

4.50

1.1

1.2

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

407

3270

1.25

4.46

1.8

1.4

20.53

11.17

iu/ml

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

295

2279

1.30

4.45

2.6

2.4

97.82

106.81

ug/min

0.15

167

1399

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

423

1.70

4.43

1.3

1.5

14.67

14.83

pmol/l

0.10

351

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

384

3067

1.26

4.43

2.9

3.2

4.09

3.27

ratio

0.20

216

1768

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

304

2360

1.29

4.43

2.3

0.87

0.83

nmol/l

0.52

255

2028

(3040151) Glucose [Moles/volume] in Capillary blood

182

1310

1.39

4.41

10.4

10.2

7.80

7.27

mmol/l

0.65

147

1104

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

107

695

1.54

4.40

3.2

2.7

45.04

41.17

1.49

383

(3033923) Metanephrine [Moles/time] in 24 hour Urine

195

2.05

4.39

1.2

1.1

0.69

0.70

umol/24h

0.07

(3020191) Ethanol [Moles/volume] in Serum or Plasma

154

1079

1.43

4.36

1.7

1.5

1.27

1.25

promille

0.04

126

828

(3006184) Hemoglobin [Mass/volume] in Capillary blood

346

2739

1.27

4.32

2.3

131.11

130.39

g/l

0.22

282

2133

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

363

2890

1.26

4.32

1.5

22.98

24.33

u/ml

0.07

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

291

2258

1.29

4.27

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

291

2258

1.29

4.27

1.3

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

166

2.11

4.14

1.4

1.3

1.93

1.44

iu/ml

0.74

(3003129) Base excess in Capillary blood by calculation

172

1243

1.38

4.10

2.4

2.3

0.62

0.58

mmol/l

0.05

160

1187

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1021

8973

1.15

4.10

3.0

2.6

67.73

69.82

ml/min/173m2

0.87

446

3723

(1001926) Buprenorphine [Presence] in Urine by Screen method

676

5762

1.18

4.06

2.6

2.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

122

2.29

4.06

1.1

1.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3044

28397

1.09

4.06

5.3

5.2

3.11

2.83

ug/l

0.18

2760

25848

(3024869) Neuronal Ab [Presence] in Serum

181

2.04

4.05

1.0

1.1

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

536

1.58

4.01

1.4

623.66

493.51

mu/l

0.70

515

(21494814) CD8 cells/Lymphocytes in Specimen

474

1.62

4.01

2.7

2.2

30.36

31.05

0.14

474

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

361

2903

1.25

3.97

1.6

1.5

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

191

1414

1.35

3.94

1.2

1.1

0.90

1.82

iu/ml

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

218

1647

1.33

3.92

1.2

1.3

68.31

59.51

u/ml

0.14

103

(3017704) Immunofixation for Urine

508

1.59

3.92

1.3

1.6

—

(4211845) Urine protein measurement

563

1.56

3.92

4.1

2.9

—

(3044927) Protein electrophoresis panel - Urine

135

944

1.43

3.91

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

131

911

1.44

3.90

1.3

1.2

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

144

2.15

3.88

1.7

1.95

2.60

mg/l

0.24

113

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

144

2.15

3.88

1.7

0.99

1.24

mg/l

0.25

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

144

2.15

3.88

1.7

2.77

3.57

mg/l

0.24

102

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

144

2.15

3.88

1.7

0.32

1.15

mg/l

3.16

106

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

144

2.15

3.88

1.7

1.39

1.83

mg/l

0.18

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

144

2.15

3.88

1.7

2.06

4.01

mg/l

1.78

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

144

2.15

3.88

1.7

2.08

2.41

mg/l

0.09

106

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

144

2.15

3.88

1.7

1.27

2.00

mg/l

0.48

103

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

144

2.15

3.88

1.7

2.29

1.78

mg/l

0.22

114

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

349

1.72

3.88

5.1

3.6

4.86

4.85

kpa

0.02

349

(3004616) Nuclear Ab [Presence] in Serum

202

1514

1.34

3.85

1.3

—

(3042631) Mycobacterium sp identified in Specimen

179

1319

1.36

3.81

2.5

2.7

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

334

2676

1.25

3.81

1.6

142.84

140.70

au/ml

0.10

768

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

131

919

1.43

3.74

1.3

1.2

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

546

1.56

3.74

1.4

73.64

72.78

0.21

525

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

441

3650

1.21

3.71

1.2

4.18

4.23

0.03

499

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2606

24238

1.09

3.70

1.8

1.7

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

446

1.61

3.69

4.2

3.4

0.96

1.26

1.11

446

(3008116) Ketones [Moles/volume] in Urine by Test strip

273

1.79

3.69

1.7

1.5

0.28

0.33

mmol/l

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

148

2.09

3.64

1.7

1.20

1.95

mg/l

0.38

109

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

135

2.14

3.63

1.5

1.4

0.34

0.53

iu/ml

0.71

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

2.53

3.60

1.2

18.83

20.50

—

(3004775) Volume in Urine collected for unspecified duration

109

745

1.46

3.59

2.4

2.3

676.32

634.76

0.54

521

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

350

1.68

3.58

5.2

3.6

10.09

10.41

kpa

0.44

350

(3035947) Staphylolysin Ab [Units/volume] in Serum

544

1.54

3.58

1.1

2.57

3.78

iu/ml

—

(3049717) Cytology report of Urine Cyto stain

421

3487

1.21

3.53

2.4

2.6

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

344

1.68

3.53

2.1

1.9

0.17

0.18

nmol/l

0.10

256

(3050129) First trimester maternal screen panel - Serum or Plasma

493

5808

0.84

3.52

1.4

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

774

8803

0.87

3.52

1.6

987.35

1000.21

mu/l

0.14

663

7535

(3009410) PHENobarbital [Moles/volume] in Serum or Plasma

5.28

3.50

5.6

8.1

99.67

88.50

umol/l

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

228

1765

1.29

3.48

1.2

7.22

17.14

u/ml

—

(44813793) Dust mix specific IgE antibody measurement

138

991

1.39

3.48

1.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

271

2150

1.26

3.41

4.7

3.7

521.20

1274.05

u/ml

0.88

128

(3006462) Nitrate [Presence] in Urine

519

1.54

3.40

4.2

3.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

640

1.48

3.39

1.0

751.18

744.96

ng/l

0.04

451

(3038026) Centromere Ab [Units/volume] in Serum

125

888

1.41

3.37

1.2

61.37

48.71

u/ml

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

182

1374

1.33

3.35

2.2

32.13

32.58

0.60

182

1363

(3034274) Bile acid [Moles/volume] in Serum --fasting

293

2351

1.25

3.35

2.7

2.5

7.76

6.99

umol/l

0.19

206

1760

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

479

4037

1.19

3.35

2.2

2.3

2.79

2.89

g/l

1.57

441

3692

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

411

4895

0.83

3.34

1.1

0.58

0.62

ratio

0.60

555

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

503

4261

1.18

3.32

2.2

2.3

3.69

g/l

0.02

465

3917

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

643

1.48

3.32

1.0

37.82

42.17

ng/l

0.50

459

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

439

3675

1.20

3.32

2.1

2.3

9.99

10.18

g/l

0.40

396

3292

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

539

1.52

3.30

1.2

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

4.34

3.29

1.1

1.4

2.14

2.04

g/l

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

141

1028

1.37

3.27

1.2

65.00

68.98

u/ml

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

503

4267

1.18

3.27

2.2

2.3

4.19

4.23

g/l

0.62

464

3924

(3036180) Methadone [Presence] in Urine

3.92

3.27

2.9

2.6

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

164

1225

1.34

3.26

1.2

47.89

39.56

u/ml

0.15

(3022621) pH of Urine by Test strip

1059

9477

1.12

3.25

2.8

2.6

6.10

6.12

0.17

696

6184

(3029634) Reagin Ab [Titer] in Serum by VDRL

254

2013

1.26

3.25

1.9

2.0

1.20

10.76

titre

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

503

4273

1.18

3.22

2.2

2.3

7.21

7.37

g/l

1.37

465

3925

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

120

854

1.40

3.22

1.6

1.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

156

1.98

3.20

1.0

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

170

1284

1.32

3.15

2.1

2.0

16.91

25.41

mg/l

2.19

467

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

129

934

1.38

3.14

1.5

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

129

934

1.38

3.14

1.5

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

129

934

1.38

3.14

1.5

1.7

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.46

3.10

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

136

997

1.36

3.08

1.4

69821.11

103739.62

e6/l

0.39

676

(3013139) Helicobacter pylori Ag [Presence] in Stool

942

8403

1.13

3.06

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

422

3549

1.19

3.06

1.3

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

173

1.90

3.05

1.7

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1261

11442

1.11

3.03

2.7

2.6

35.80

42.46

u/l

0.77

1050

9699

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.58

3.02

1.1

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

846

7505

1.13

3.02

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

302

2463

1.23

3.01

3.7

3.2

1.48

1.57

mmol/l

1.12

292

2389

(3012787) Ethosuximide [Moles/volume] in Serum or Plasma

9.97

2.97

2.0

3.8

315.40

330.40

umol/l

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

154

1.94

2.96

1.0

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

470

4004

1.18

2.94

1.9

—

(3024928) Oxygen saturation in Venous blood

351

2917

1.21

2.91

6.7

4.3

65.47

62.62

1.80

334

2836

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

122

888

1.37

2.91

1.7

1.5

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

107

762

1.40

2.90

1.5

24.50

23.23

u/ml

0.08

145

(3052851) Hemolysis interference index of Serum or Plasma

383

3212

1.19

2.89

3.5

3.1

2.66

2.37

index

0.24

217

1690

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

639

1.44

2.87

1.0

305.02

325.22

ng/l

0.29

463

(3006571) Granulocytes/Leukocytes in Synovial fluid

164

1252

1.31

2.85

1.5

1.6

52.74

56.53

0.57

104

791

(46235355) HIV 1 and 2 tests - Meaningful Use set

3076

29076

1.07

2.82

2.2

2.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

207

2594

0.79

2.81

1.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2414

22625

1.08

2.80

4.5

4.3

22.37

21.97

0.58

1102

10470

(1002224) Polysomnography panel

689

6064

1.14

2.80

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

435

3701

1.18

2.79

2.3

0.99

0.79

g/l

0.46

383

3197

(3016750) Collection duration of Urine

553

1.46

2.77

2.4

2.3

514.84

498.63

min

0.90

427

(3001964) Herpes simplex virus Ag [Presence] in Specimen

345

1.59

2.77

1.4

1.5

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

131

1.98

2.72

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.19

2.71

1.2

1.56

1.61

umol/24h

0.11

(3026250) Tacrolimus [Mass/volume] in Blood

624

1.42

2.66

50.0

42.9

7.11

7.22

ug/l

0.22

569

(3016038) Potassium [Moles/volume] in Urine

108

785

1.37

2.63

1.6

1.4

33.65

34.62

mmol/l

0.16

701

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

3.14

2.63

1.4

1.8

164.00

216.38

nmol/l

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

122

905

1.35

2.62

1.4

11.68

11.92

umol/l

0.13

111

856

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

133

1000

1.33

2.61

3.0

2.9

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

266

1.65

2.58

1.2

1.3

51.08

38.11

1.10

186

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

121

899

1.35

2.58

2.9

3.0

98.18

98.26

0.01

114

848

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

637

1.41

2.57

1.1

—

(3036603) Volume of Urine

117

866

1.35

2.56

1.7

1.6

1842.94

2003.13

1.20

112

852

(3016650) Hepatitis A virus Ab [Presence] in Serum

268

2206

1.22

2.51

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

484

1.47

2.49

3.3

4.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

592

5207

1.14

2.47

1.4

1.3

202.17

225.73

miu/ml

0.79

234

2472

(3016879) Cocaine [Presence] in Urine

765

6837

1.12

2.47

2.5

2.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

134

1018

1.32

2.47

1.2

1.3

2.28

3.46

u/ml

0.47

602

(3003329) Lymphocytes/Leukocytes in Synovial fluid

126

949

1.33

2.46

1.5

1.6

31.98

31.83

0.02

572

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

4.36

2.46

1.0

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

206

1655

1.24

2.44

1.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

147

1134

1.30

2.43

1.4

1.56

1.47

nmol/l

0.35

130

1019

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.45

2.43

1.0

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

572

1.41

2.37

1.8

2.0

7.57

7.95

mmol/l

0.40

572

(43055514) Macroprolactin [Presence] in Serum or Plasma

424

1.48

2.37

1.4

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

172

1359

1.27

2.36

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.11

2.36

1.1

10.68

12.23

u/l

0.10

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

4.11

2.35

1.0

1.2

1.21

1.29

mg/l

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

155

1210

1.28

2.35

1.2

115.87

65.03

u/l

1.01

136

1060

(3000764) Benzodiazepines [Presence] in Urine

815

7334

1.12

2.35

2.5

2.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

127

966

1.31

2.34

1.3

6.26

6.24

mmol/l

0.04

118

896

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

643

1.38

2.30

1.5

1.7

4.95

4.87

nmol/l

0.01

519

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

142

1100

1.29

2.29

2.3

1.8

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

371

3178

1.17

2.26

1.4

21.69

51.10

u/ml

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

308

1.56

2.26

8.1

6.5

6.05

6.01

kpa

0.16

282

(3020876) Protein [Mass/time] in 24 hour Urine

165

1308

1.26

2.23

2.5

1.25

1.31

g/24h

0.11

100

771

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

351

0.51

2.21

5.7

6.3

8.56

8.69

0.04

351

(40761995) Spermatozoa Progressive [#/volume] in Semen

351

0.51

2.21

2.8

3.2

40.89

45.28

0.47

351

(3036005) Urine sediment comments by Light microscopy Narrative

5.54

2.21

1.0

1.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

632

1.38

2.19

1.6

1.7

1.23

1.31

nmol/l

0.23

468

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

351

1.51

2.18

2.9

3.4

2.14

1.94

ratio

0.45

322

(3028300) Cannabinoids [Presence] in Urine

818

7397

1.11

2.17

2.5

2.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

232

1915

1.21

2.16

1.3

30.31

31.46

u/l

0.04

214

1670

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

117

892

1.31

2.15

1.2

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

229

1891

1.21

2.13

1.2

0.71

1.06

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

418

1.46

2.13

1.2

—

(3027008) Opiates [Presence] in Urine

815

7378

1.11

2.13

2.4

2.0

—

(3004451) EKG impression Narrative

570

1.38

2.09

1.4

1.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

380

1.47

2.06

1.2

—

(3038515) Glucose [Moles/volume] in Venous blood

243

2026

1.20

2.06

3.7

3.3

7.45

7.54

mmol/l

0.18

237

1969

(36303858) Crystals [Presence] in Urine

3.49

2.04

1.0

1.1

—

(3011985) Renin [Units/volume] in Plasma

215

1774

1.21

2.04

1.6

41.22

72.73

mu/l

3.22

197

1603

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

650

1.35

2.02

1.3

93.33

55.47

titre

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

392

1.45

1.98

2.6

2.5

145.56

121.27

ng/l

0.46

254

(3016244) Insulin [Units/volume] in Serum or Plasma

137

1081

1.27

1.96

2.9

3.4

23.71

24.97

mu/l

0.21

132

1023

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

338

2913

1.16

1.95

1.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

655

1.34

1.94

1.2

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

346

2989

1.16

1.94

1.4

228.00

251.59

u/ml

1.08

215

1826

(3006922) Hepatitis E virus Ab [Presence] in Serum

131

1030

1.27

1.94

1.0

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

133

1048

1.27

1.93

2.3

2.4

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

682

1.33

1.92

1.5

1.6

7.78

6.64

u/l

0.36

554

(3038071) Oxygen [Partial pressure] in Mixed venous blood

281

1.53

1.91

8.2

6.5

5.60

5.36

kpa

0.26

281

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

631

1.35

1.91

1.1

1.2

75.98

82.34

u/l

0.46

564

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

260

2199

1.18

1.90

1.1

—

(1761868) Lipid panel - Serum or Plasma

4579

47108

0.95

1.90

3.2

2.9

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

692

1.33

1.90

1.7

1.6

194033.00

1778553.19

iu/ml

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

210

1743

1.20

1.90

1.7

—

(4035726) Immunohistochemistry procedure

1043

9613

1.09

1.89

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

238

2806

0.84

1.88

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

238

2804

0.84

1.87

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

587

5267

1.12

1.85

1.4

1.3

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

456

4034

1.13

1.83

1.7

1.8

42.87

41.00

nmol/l

0.85

444

3948

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

144

1.73

1.82

10.4

11.1

5.38

5.51

mmol/l

0.08

144

(3038702) Sodium [Moles/volume] in Capillary blood

4.16

1.82

4.0

3.6

139.00

mmol/l

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

689

1.32

1.81

1.7

1.9

143.93

138.75

0.25

656

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

10197

100400

1.05

1.80

24.3

18.7

332.63

332.70

g/l

0.35

10143

99854

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

2.75

1.78

1.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

264

2252

1.17

1.77

1.4

21.84

25.19

u/l

0.97

212

1857

(3008757) Leukocyte morphology finding [Identifier] in Blood

146

1178

1.24

1.76

4.0

3.9

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

287

1.50

1.76

1.3

1.2

—

(3002256) Pathology report gross observation

1623

15265

1.07

1.74

1.3

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

625

1.33

1.73

1.1

1.2

21.94

22.79

u/l

0.06

561

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.66

1.71

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

621

6816

0.90

1.70

1.7

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

325

2828

1.15

1.69

2.3

0.00

g/l

-0.00

305

2660

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

247

2105

1.17

1.69

1.3

3.25

3.31

u/ml

0.02

111

784

(3004716) Salmonella sp identified in Stool by Organism specific culture

728

6641

1.10

1.69

1.4

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

362

3176

1.14

1.68

2.3

2.2

0.00

0.03

g/l

2.47

333

2865

(3027944) Amphetamines [Presence] in Urine

796

7295

1.09

1.67

2.4

2.0

—

(3006576) Bicarbonate [Moles/volume] in Blood

333

1.44

1.64

7.3

6.6

24.56

24.71

mmol/l

0.09

307

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

683

1.30

1.64

1.2

1.3

31.50

12.91

u/l

0.57

630

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

284

1.48

1.63

1.3

11.28

11.53

pmol/l

0.02

108

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

571

1.33

1.63

1.8

1.9

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

571

1.33

1.63

1.8

1.9

—

(1761482) Bacteria [#/volume] in Urine by Culture

269

2319

1.16

1.61

4.2

4.0

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

221

1.54

1.59

2.9

34.45

32.02

mg/l

—

(4024509) Urine culture

586

5310

1.10

1.58

2.3

1.9

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

182

1.59

1.58

6.1

7.2

11.01

10.59

0.39

182

(40761539) Cells [Type] in Urine sediment by Light microscopy

262

1.49

1.58

1.5

1.2

—

(3003694) ABO and Rh group [Type] in Blood

3825

36934

1.05

1.57

1.5

1.6

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

222

1.53

1.57

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

206

1745

1.18

1.55

1.4

1.3

0.50

0.23

nmol/l

—

102

(3051387) C reactive protein [Mass/volume] in Capillary blood

267

2312

1.15

1.52

4.7

3.3

24.49

26.61

mg/l

0.48

187

1574

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

130

1057

1.23

1.51

1.4

73.17

78.15

0.31

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

150

1238

1.21

1.51

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

510

1.33

1.50

1.2

30.61

12.25

u/ml

0.28

328

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

327

2877

1.14

1.49

1.8

1.9

186.81

198.48

pmol/l

1.21

308

2743

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

324

1.42

1.48

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

324

1.42

1.48

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

324

1.42

1.48

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

324

1.42

1.48

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

154

1.62

1.48

5.3

3.9

—

(3012565) Volume of 24 hour Urine

555

1.31

1.47

2.2

2.1

1797.21

1955.05

0.82

504

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

343

3033

1.13

1.45

2.3

2.2

0.00

g/l

0.80

305

2666

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

194

1646

1.18

1.45

1.3

1.4

352.37

369.54

pmol/l

0.14

162

1408

(3051611) Lipemic interference index of Serum or Plasma

136

1117

1.22

1.45

4.0

3.3

16.00

14.39

index

0.57

690

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

483

4358

1.11

1.44

2.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1116

10440

1.07

1.44

2.2

2.0

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

199

1695

1.17

1.42

1.4

1.3

4.74

2.54

nmol/l

0.21

193

1640

(3016273) Islet cell 512 Ab [Units/volume] in Serum

125

1.68

1.41

1.0

—

(3000475) Leukocytes [#/volume] in Synovial fluid

313

2758

1.13

1.41

1.6

12079.54

13561.18

e6/l

0.26

242

1938

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

286

2506

1.14

1.40

1.7

—

(3002619) Bacteria identified in Specimen by Culture

311

1.41

1.40

1.1

1.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

270

1.44

1.39

1.7

1.6

0.42

0.40

ug/l

0.10

192

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

675

1.27

1.38

1.3

120.00

480.43

titre

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

100

801

1.25

1.36

1.1

1.2

1.05

1.06

ratio

0.88

665

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

695

1.26

1.35

1.3

1.2

30.57

23.55

u/l

0.48

576

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

401

3600

1.11

1.34

1.4

1.3

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

477

1.32

1.33

1.3

1.4

511.25

187.88

nmol/24h

0.33

477

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

205

1763

1.16

1.32

1.1

1.51

1.49

g/l

0.37

189

1612

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

220

1903

1.16

1.32

1.1

119.88

116.03

0.91

196

1725

(3000012) Reticulocyte production index

174

1478

1.18

1.31

2.3

2.1

1.01

0.90

0.76

120

978

(3000093) Morphology [Interpretation] in Blood Narrative

133

1103

1.20

1.31

1.2

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

208

1.49

1.30

1.2

1.3

96.83

119.31

mg/l

0.08

150

(3034891) Synovial lining cells/cells in Synovial fluid

505

1.30

1.3

1.6

1.73

4.52

1.89

108

(3006270) Folate [Moles/volume] in Blood

106

860

1.23

1.30

1.2

1.1

378.83

371.49

nmol/l

0.13

742

(3017509) Phencyclidine [Presence] in Urine

168

1.54

1.29

1.5

1.7

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

126

1042

1.21

1.28

1.0

1.1

288.68

287.62

mg/l

0.06

116

952

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.00

1.26

1.0

1.1

197.27

447.69

u/l

1.14

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

508

1.30

1.26

1.0

0.27

1.01

u/ml

2.18

501

(3022493) Free Hemoglobin [Mass/volume] in Plasma

552

1.28

1.25

3.9

4.9

2269.63

832.37

mg/l

0.28

409

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

146

1.57

1.24

1.5

1.8

—

(4034850) Laboratory test

375

3374

1.11

1.23

10.4

9.6

—

(40768443) Skin Pathology biopsy report

575

5282

1.09

1.22

1.2

—

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

100

1.70

1.22

1.6

1.3

1.25

1.41

ml/s/173m2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

108

1.66

1.20

1.4

1.5

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1350

12793

1.06

1.20

4.9

4.6

32.51

32.35

0.20

972

8852

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

234

2051

1.14

1.19

1.3

3.56

4.13

u/ml

0.56

114

969

(3035880) pH of Pleural fluid

495

1.29

1.19

1.3

7.40

0.03

336

(3033099) Centromere Ab [Titer] in Serum

288

1.39

1.19

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

172

1475

1.16

1.18

1.3

0.17

0.20

nmol/l

0.90

130

1148

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.30

1.18

5.7

1.4

1.55

2.57

mu/l

—

(40765096) Chromosome analysis panel by Banding

331

1.36

1.18

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

126

1053

1.19

1.17

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

152

1292

1.18

1.17

1.4

—

titre

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

294

2618

1.12

1.17

1.5

0.35

0.41

nmol/l

0.51

210

2044

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

719

1.24

1.16

1.3

1.2

126.10

88.87

u/l

1.00

611

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

188

1626

1.16

2.4

2.5

27.52

25.64

iu/ml

0.10

135

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

454

1.30

1.15

1.2

114.20

109.50

0.61

409

(3002621) Streptococcal DNAse B [Units/volume] in Serum

182

1.48

1.14

1.1

366.50

294.80

u/ml

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

125

1048

1.19

1.13

1.0

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

152

0.52

1.13

3.6

6.0

10.68

8.06

mmol/l

—

152

(3042733) HLA Ab [Presence] in Serum

429

1.30

1.13

4.7

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.33

1.12

1.3

1.2

34.91

30.01

mg/24h

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.33

1.12

1.0

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

129

1088

1.18

1.10

1.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.25

1.10

1.0

1.1

18.88

33.44

umol/24h

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

151

1.52

1.10

4.2

3.6

10.12

4.86

0.55

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

157

1814

0.86

1.09

3.6

3.9

36.28

31.37

u/ml

0.24

152

1763

(40768446) Kidney Pathology biopsy report

529

1.26

1.08

1.9

1.7

—

(3014271) Vancomycin [Susceptibility]

415

1.30

1.08

3.0

2.9

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

138

1174

1.17

1.07

1.3

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

306

2749

1.11

1.07

1.2

1.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

169

1.48

1.05

1.0

1.1

—

(3045788) Cell count panel - Pleural fluid

113

947

1.19

1.05

1.5

1.4

—

(3000330) Specific gravity of Urine by Test strip

593

5498

1.08

1.05

3.6

3.2

1.02

ratio

0.06

535

4896

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

124

1050

1.18

1.03

1.2

296.43

177.67

titre

0.49

176

(3045142) Bone marrow Pathology biopsy report

145

1245

1.16

1.02

1.3

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

233

2068

1.13

1.02

1.2

1.1

768.04

5751.16

iu/ml

0.53

472

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

134

1144

1.17

1.01

1.1

7.95

7.81

iu/ml

0.02

286

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

128

1089

1.17

1.01

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

490

1.26

1.01

1.2

0.33

0.29

g/l

1.48

400

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

128

1091

1.17

0.99

1.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

188

1.43

0.99

1.4

1.7

9.78

278987.38

nmol/l

1.28

157

(3032057) Clostridioides difficile [Presence] in Stool

205

1.41

0.99

2.0

1.9

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

132

1129

1.17

0.98

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

123

1046

1.17

0.98

1.2

114.38

112.66

pmol/l

0.14

123

1046

(3027035) Albumin [Mass/time] in 24 hour Urine

1.61

0.98

1.1

1.3

—

526.17

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1815

17429

1.04

0.98

1.9

1.8

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.83

0.98

1.1

1.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

129

1103

1.17

0.97

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

173

1513

1.14

0.96

1.3

1.4

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

144

1244

1.16

0.95

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

225

2003

1.12

0.95

1.1

2.32

3.51

eliau/ml

1.15

952

(3018333) Ribosomal P Ab [Presence] in Serum

120

1023

1.17

0.94

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.68

0.94

1.5

—

(3004809) Band form neutrophils/Leukocytes in Blood

209

1855

1.13

0.93

3.8

3.6

1.32

1.50

0.23

184

1675

(3009871) Measles virus Ab [Titer] in Serum

514

1.24

0.93

1.5

1.7

2741.82

2845.41

titre

0.04

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

165

1443

1.14

0.93

1.1

96.70

96.30

0.07

152

1357

(3023199) Leukocytes [#/volume] in Pleural fluid

135

1165

1.16

0.92

1.5

8054.20

3226.67

e6/l

0.52

101

817

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.73

0.92

8.3

8.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

833

1.19

0.91

1.2

1.3

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

277

1.33

0.91

3.3

2.5

1.08

1.55

mmol/l

1.11

201

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.71

0.91

1.1

1.3

—

(21494434) Karyotype in Bone marrow

111

944

1.17

0.91

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.66

0.90

1.0

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

969

0.83

0.90

1.0

1.1

1.07

1.44

u/ml

0.21

306

(3025468) Yersinia sp identified in Specimen by Organism specific culture

162

1420

1.14

0.89

1.3

1.4

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

662

1.21

0.89

1.2

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1309

12513

1.05

0.88

2.4

2.2

—

(40758358) Immune stain study

1.90

0.88

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.69

0.87

1.4

2.0

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

127

1.49

0.87

2.1

1.7

—

(3022670) pH of Venous cord blood

1.64

0.87

1.0

1.1

—

(4195642) Thrombophilia screening test

213

1904

1.12

0.86

1.2

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

120

1033

1.16

0.86

1.4

1.3

5.05

5.39

umol/l

0.45

104

919

(3040893) Potassium [Moles/volume] in Capillary blood

1.81

0.85

4.4

2.5

4.78

4.52

mmol/l

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.81

0.85

2.4

1.9

218.38

264.05

ug/l

—

(3032641) Amino acids panel - Urine

1.81

0.85

1.0

1.2

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

178

1.40

0.84

6.6

5.4

33.94

39.64

ug/min

0.19

121

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

128

1.48

0.84

1.1

1.5

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.66

0.84

1.6

1.5

—

(40763791) Oxygen content in Venous blood by calculation

1.93

0.84

5.0

9.0

12.08

11.88

ml/dl

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

162

1428

1.13

0.83

1.3

1.4

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

486

1.23

0.83

1.3

1.2

112.13

106.70

0.41

447

(3017569) Oxygen content in Arterial blood

559

1.21

0.82

1.8

2.2

16.36

16.05

0.35

559

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

239

1.34

0.82

3.3

2.6

134.56

154.87

ug/l

0.05

239

(3005988) Vibrio sp identified in Specimen by Organism specific culture

162

1430

1.13

0.82

1.3

1.4

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

551

1.21

0.81

1.0

1.1

95.60

93.65

0.24

438

(3047189) Immunofixation for 24 hour Urine

452

1.24

0.81

1.6

1.8

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

122

1058

1.15

0.80

1.2

—

(44806420) Estimation of glomerular filtration rate

158

1395

1.13

0.80

2.4

2.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

151

1330

1.13

0.80

1.5

1.4

34.17

32.71

g/l

0.72

137

1208

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

471

1.23

0.80

1.1

90.80

91.12

0.03

207

(3024522) Salmonella sp identified in Specimen by Organism specific culture

167

1481

1.13

0.79

1.3

1.4

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

172

1.39

0.79

1.8

1.9

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

104

893

1.16

0.79

1.3

796.75

365.51

u/l

1.01

844

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.72

0.78

1.3

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

409

1.24

0.78

1.6

2.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.52

0.78

1.0

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

482

1.22

0.77

2.5

2.4

—

(3032868) Hemoglobin electrophoresis panel in Blood

131

1.45

0.77

1.5

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

803

1.17

0.76

1.7

1.5

7.27

7.00

ug/l

0.09

734

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

182

1.37

0.76

1.1

1.0

1.05

0.19

u/ml

0.37

120

(3001686) Cold agglutinin [Titer] in Serum or Plasma

208

1.34

0.76

1.4

1.3

74.00

107.00

titre

—

(4094501) Cardiovascular stress test using bicycle ergometer

321

2954

1.09

0.75

1.1

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

261

1.30

0.74

1.0

3.87

3.36

kpa

0.31

221

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

175

1.37

0.73

1.6

1.7

18.00

16.33

nmol/l

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

459

1.22

0.72

1.1

1.2

86.13

90.19

0.28

208

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

660

1.18

0.72

1.2

—

(4268621) Lupus anticoagulant assay

168

1503

1.12

0.71

2.4

2.3

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.57

0.70

1.0

1.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

246

1.30

0.70

1.2

250.91

317.32

pmol/l

1.04

184

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

134

1.41

0.70

1.0

1.3

97.38

271.19

u/l

0.35

101

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

109

1.46

0.70

1.1

1.2

0.08

0.46

u/ml

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.70

0.69

1.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

203

1.33

0.69

2.4

2.2

7.71

7.26

mmol/l

0.18

121

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

126

1.43

0.69

1.2

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

160

1.37

0.69

1.1

1.2

5.88

5.74

mmol/l

0.26

160

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

186

1.34

0.68

2.4

1.9

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.85

0.68

1.8

1.4

1.38

1.92

mmol/24h

—

(3010375) cycloSPORINE [Mass/volume] in Blood

600

1.18

0.68

28.7

29.2

145.22

117.60

ug/l

0.58

498

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

169

1.36

0.68

1.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.66

0.68

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

711

1.17

0.68

1.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

440

4119

1.07

0.68

1.6

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.64

0.67

7.2

5.9

—

(3022475) Manganese [Moles/volume] in Blood

1.55

0.67

1.3

0.15

0.16

umol/l

1.09

(3018001) Oat IgE Ab [Units/volume] in Serum

110

1.45

0.67

1.0

0.18

0.33

u/ml

0.36

(3006598) pH of Arterial cord blood

266

1.28

0.66

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

266

1.28

0.66

1.0

-3.37

-2.47

mmol/l

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

266

1.28

0.66

1.0

6.80

7.36

kpa

1.02

227

(3026726) Creatinine [Moles/volume] in Specimen

0.52

0.66

2.2

2.7

183.80

409.71

umol/l

—

(37021550) Renin [Units/volume] in Plasma --upright

232

1.29

0.64

1.6

1.3

54.54

103.07

mu/l

0.70

181

(3044007) Cell count panel - Peritoneal fluid

330

1.24

0.64

1.8

2.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

448

1.20

0.64

1.0

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

239

2192

1.09

0.64

1.6

1.5

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

403

1.21

0.63

1.7

2.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

403

1.21

0.63

1.7

2.2

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.72

0.63

1.2

1.1

235.58

263.45

u/ml

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

494

4655

1.06

0.63

1.5

—

(42870560) Thyrotropin [Units/volume] in Cord blood

313

1.24

0.63

1.0

9.53

9.04

mu/l

0.18

260

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

322

1.24

0.63

1.4

1.9

35611.79

15768.17

e6/l

0.35

162

(3008536) Aspergillus sp Ab [Presence] in Serum

242

1.28

0.62

1.7

2.3

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

1.49

0.62

1.2

1.3

128.43

104.38

ug/l

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

287

1.25

0.62

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

323

1.24

0.62

1.5

1.7

10.31

9.15

ug/l

0.71

323

(40768800) Prostate Pathology biopsy report

154

1699

0.90

0.62

1.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

607

1.17

0.61

1.1

1.2

1.33

13.00

u/ml

—

(3024932) HLA-DR beta [Type]

396

1.21

0.61

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

164

1.34

0.61

1.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

113

1000

1.13

0.61

2.0

2.2

—

(44786800) Granulocytes/Leukocytes in Body fluid

113

1.41

0.60

1.3

36.91

23.84

0.47

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

164

1485

1.10

0.59

1.3

1.4

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

105

1.42

0.59

1.0

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.52

0.58

3.5

1.3

—

(3007463) Buprenorphine [Presence] in Urine

1.52

0.58

9.2

4.9

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

629

1.16

0.58

1.5

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

114

1.40

0.58

1.1

17.28

22.08

u/l

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.46

0.57

1.4

5.4

—

(3028717) Thiamine [Mass/volume] in Blood

184

1.30

0.56

1.3

1.2

58.96

64.29

ug/l

0.74

184

(3028308) Erythrocytes [#/volume] in Pleural fluid

115

1025

1.12

0.56

1.5

1.4

56792.53

52688.66

e6/l

0.09

573

(3027456) Digoxin [Moles/volume] in Serum or Plasma

195

1787

1.09

0.56

3.4

3.2

0.78

0.82

nmol/l

0.87

160

1426

(3042010) Triglyceride [Moles/volume] in Pleural fluid

158

1.33

0.56

1.1

1.2

4.43

1.72

mmol/l

0.66

109

(3024471) HLA-A [Type]

401

1.19

0.55

1.0

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

238

1.26

0.55

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

194

1.29

0.54

4.4

7.8

61.57

69.82

0.53

154

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

125

0.64

0.54

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

560

1.16

0.53

1.7

2.39

2.83

u/field

0.19

412

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

204

0.73

0.53

1.2

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

663

1.14

0.53

1.5

—

(3030313) Adrenal Ab [Titer] in Serum

151

1.32

0.53

1.3

1.2

—

38.33

titre

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.53

0.53

1.0

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

220

2035

1.08

0.52

1.4

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

711

1.14

0.52

1.2

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1732

16855

1.03

0.51

3.1

0.79

0.75

ug/l

0.33

1113

10508

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

217

2009

1.08

0.50

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

378

1.19

0.50

1.6

2.2

1242.28

2806.82

e6/l

0.32

255

(3027231) Wheat IgE Ab [Units/volume] in Serum

369

1.19

0.50

1.1

1.2

1.77

6.77

u/ml

0.99

332

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

723

1.13

0.50

1.2

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

695

1.13

0.50

1.5

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

269

2513

1.07

0.49

1.2

1.1

32.21

15.80

au/ml

1.09

608

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

162

1.29

0.49

2.6

2.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.52

0.48

1.0

1.1

0.05

0.04

u/ml

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.49

0.47

1.1

1.3

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

163

1.29

0.47

2.5

4.3

18.91

22.91

mg/l

0.85

154

(4146454) Self-monitoring of blood glucose

116

1049

1.10

0.47

3.2

2.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

495

4719

1.05

0.46

1.5

1.4

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.41

0.46

1.6

1.5

372.08

299.81

umol/24h

0.24

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

146

1.30

0.46

2.5

4.3

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

206

2202

0.93

0.45

1.1

1.05

0.43

u/ml

0.29

753

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.38

0.45

13.1

5.1

101.31

101.78

g/l

0.05

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

138

1.30

0.44

1.9

2.7

57.55

68.42

pmol/l

0.27

121

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

486

1.15

0.44

1.9

2.0

127.82

126.56

ug/min

0.01

113

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

192

1.25

0.44

1.3

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

195

2083

0.93

0.43

1.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

837

1.11

0.42

1.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

686

1.12

0.42

1.7

2.0

85.73

103.46

ng/l

1.24

686

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.56

0.42

1.4

1.2

—

mmol/l

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

530

0.86

0.42

1.8

1.9

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

530

0.86

0.42

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

574

1.13

0.41

1.7

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

574

1.13

0.41

1.7

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

574

1.13

0.41

1.7

1.9

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

285

1.19

0.41

1.5

1.4

2.19

2.52

0.10

239

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1872

18303

1.02

0.41

2.4

2.2

—

(3025577) Chromium [Mass/volume] in Blood

518

1.14

0.41

2.1

2.2

1.87

2.53

ug/l

0.89

436

(3020650) Glucose [Presence] in Urine

462

1.14

0.40

1.6

0.11

0.03

estimate

0.49

462

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

575

1.13

0.40

1.6

1.9

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

108

1177

0.91

0.40

1.6

1.5

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

182

0.77

0.39

1.1

2.49

0.64

u/ml

0.42

182

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

527

0.87

0.39

1.0

11.57

12.36

u/ml

0.08

345

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

141

1.27

0.39

1.1

—

(3012441) Differential panel - Pleural fluid

111

1014

1.09

0.39

1.5

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

1.42

0.39

1.0

0.01

0.98

u/ml

—

(4281824) Cell count and differential, peritoneal fluid

116

1258

0.92

0.39

1.1

1.2

—

(3003157) Bacteria [#/volume] in Mother's milk

1.39

0.38

7.0

7.6

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

115

1.30

0.38

1.0

160.20

165.09

g/l

0.38

115

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

409

1.15

0.38

2.6

0.61

mmol/l

0.15

409

(3024891) Influenza virus A+B Ag [Presence] in Specimen

381

3636

1.05

0.37

1.2

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.35

0.37

1.0

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

206

1.21

0.37

1.2

1.1

0.66

2.93

u/ml

0.55

(3052592) Norovirus Ag [Presence] in Stool

188

1.22

0.36

1.5

1.3

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.28

0.36

1.1

1.0

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

1.39

0.36

1.1

1.9

162.00

194.88

ng/l

—

(40762887) Creatinine [Moles/volume] in Blood

1.39

0.36

1.5

—

(44806071) Cardiolipin IgM antibody measurement

201

0.79

0.36

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

534

1.12

0.35

2.1

2.2

2.76

3.68

ug/l

0.52

494

(3014891) Appearance of Pleural fluid

122

0.74

0.35

1.3

1.6

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

272

1.17

0.35

1.3

2.79

378.21

ug/l

2.01

136

(3021162) Amylase [Enzymatic activity/volume] in Specimen

200

0.80

0.35

4.6

2.9

3127.69

2286.43

u/l

0.16

185

(3017354) Segmented neutrophils/Leukocytes in Blood

129

1195

1.08

0.34

3.9

3.6

57.40

56.55

0.17

106

1040

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

319

1.16

0.34

1.1

1.2

65.80

70.66

—

(3029396) Erythrocyte agglutination [Presence] in Blood

488

0.88

0.34

3.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

841

1.09

0.34

1.9

1.8

88.91

1071.64

pmol/l

0.74

118

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

125

1158

1.08

0.34

5.0

5.1

296.18

81.20

u/ml

1.00

397

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

211

1992

1.06

0.33

1.1

2.74

2.79

0.03

319

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

165

0.79

0.32

1.0

1.1

2.02

0.54

u/ml

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

401

0.87

0.32

1.2

1.1

67.30

59.32

u/ml

0.25

392

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.27

0.32

1.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

1058

0.92

0.32

1.1

1.2

0.96

6.98

u/ml

1.36

344

(3051339) Copper [Moles/volume] in Blood

1.35

0.31

1.3

1.2

16.64

16.62

umol/l

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

192

1.19

0.31

1.3

1.4

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.34

0.31

1.1

1.0

8.66

8.30

mmol/l

—

(3041672) Baker's yeast Ab [Presence] in Serum

110

1.27

0.31

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.32

0.30

5.9

4.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

174

1.20

0.30

1.6

1.5

44.36

73.24

ng/l

0.58

106

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

408

1.12

0.30

2.3

1.9

40.65

40.24

g/l

0.26

408

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

503

1.11

0.30

2.3

2.4

9.41

9.31

mg/l

0.05

434

(40763590) HLA-DQ beta [Type]

1.27

0.30

1.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

665

6453

1.03

0.29

2.7

3.4

53.13

52.32

u/ml

0.03

642

6237

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.33

0.29

1.0

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

513

0.89

0.29

1.1

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

513

0.89

0.29

1.1

1.4

—

(40760410) HLA-B [Type] by High resolution

1.25

0.29

1.0

—

(3013862) HLA-DP [Type]

1.25

0.29

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.25

0.29

1.0

—

(40760409) HLA-A [Type] by High resolution

1.25

0.29

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

102

1.27

0.29

1.0

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

117

1090

1.07

0.29

1.2

2.28

2.29

u/ml

0.00

445

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

821

1.08

0.28

1.8

2.0

2.78

1.65

u/field

0.94

465

(3036071) Salmonella sp Ab [Titer] in Serum

428

0.88

0.28

1.2

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

176

1.19

0.28

1.8

1.5

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

103

1.26

0.27

1.0

1.1

0.00

1.75

u/ml

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

250

2602

0.96

0.27

1.1

4.99

4.78

u/ml

0.05

138

1388

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

289

1.14

0.27

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

289

1.14

0.27

1.1

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

289

1.14

0.27

1.1

1.2

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

257

0.85

0.27

2.0

4.5

36.50

59.11

u/l

1.34

248

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.30

0.25

1.0

1.1

—

0.22

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

339

3266

1.04

0.25

1.5

63.83

59.60

ug/l

0.79

339

3266

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

291

1.13

0.25

1.9

1.7

—

(40765089) Chromosome analysis panel - Blood by G-banded

578

1.09

0.24

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.73

0.24

1.0

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.73

0.24

1.3

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

311

1.12

0.24

1.3

1.2

39.39

38.93

g/l

0.09

163

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

274

1.13

0.23

1.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

216

2068

1.04

0.23

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

909

1.06

0.22

2.7

3.0

101.12

55.75

mg/l

0.40

676

(3043410) Blood group antigens tested for on Red Blood Cells

303

1.12

0.22

2.0

1.7

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

5.2

—

(3041198) Albumin [Mass/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

6.4

—

205.27

—

(3007456) Orange IgE Ab [Units/volume] in Serum

1.19

0.21

1.2

1.0

0.04

0.11

u/ml

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

144

1.18

0.21

1.2

1.1

5.09

9.08

u/ml

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

334

0.90

0.20

1.2

71.67

67.91

ug/l

0.20

334

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

495

4820

1.02

0.20

1.6

13.28

13.93

u/ml

0.08

114

1211

(3011648) Oxygen content in Venous blood

139

1322

1.05

0.20

6.7

4.9

11.57

10.96

1.09

139

1317

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.20

0.0

1.4

—

6.45

—

(3012138) Guinea pig epithelium IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

0.78

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.20

0.0

1.4

—

13.92

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.25

0.20

1.3

1.1

2.47

0.97

u/ml

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

461

4708

0.98

0.20

1.7

4.74

4.33

mg/l

0.24

345

3453

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

117

1.19

0.20

1.1

0.03

u/ml

0.09

117

(3041806) Other cells [#/volume] in Blood by Manual count

684

0.93

0.19

1.5

0.51

0.52

e9/l

0.02

684

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

183

1.14

0.19

1.2

1.1

0.09

0.58

u/ml

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

405

0.91

0.19

1.4

1.2

42.75

8.70

u/ml

0.58

289

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

155

1.16

0.19

2.5

1.9

1.92

1.58

mg/l

0.52

134

(3010937) Rubella virus Ab [Presence] in Serum

109

1.19

0.18

1.0

1.1

—

(40768793) Breast Pathology biopsy report

296

2870

1.03

0.18

1.3

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

194

1.13

0.18

1.5

1.9

20.15

47.91

pmol/l

2.67

164

(3046861) Legionella sp Ag [Presence] in Urine

1.16

0.17

1.1

1.0

—

(4015189) Microbial culture of sputum

242

1.11

0.17

2.4

2.1

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

204

1.12

0.17

1.2

1.1

0.23

1.33

u/ml

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

473

1.08

0.17

1.1

1.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.76

0.17

1.6

2.3

0.58

0.63

ug/l

—

(37208534) Antinuclear antibody arbitrary concentration in serum

455

1.07

0.16

1.0

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

835

1.05

0.16

1.2

1.3

172.88

182.27

pmol/l

0.25

835

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

203

0.88

0.15

1.1

1.0

5.16

7.22

u/ml

0.44

203

(40762814) Titanium [Mass/volume] in Blood

139

1.15

0.15

2.4

2.5

3.08

4.08

ug/l

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

348

0.92

0.15

1.1

33.08

33.32

iu/ml

0.01

348

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.15

0.15

1.2

2.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.15

0.15

1.1

1.2

—

(3019174) dRVVT (LA screen)

111

1.17

0.15

1.1

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

130

1.15

0.15

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

221

2143

1.03

0.14

3.0

3.6

113.32

702.51

u/ml

3.12

202

1953

(3005082) Progesterone [Moles/volume] in Serum or Plasma

980

0.96

0.14

1.4

1.5

32.39

35.77

nmol/l

0.49

896

(3016031) Almond IgE Ab [Units/volume] in Serum

159

1.13

0.14

1.1

0.78

1.43

u/ml

0.52

102

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

848

1.05

0.14

1.7

1.6

—

(40768806) Pleura Pathology biopsy report

1009

0.96

0.14

1.7

1.5

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

0.81

0.13

1.1

1.0

—

4.30

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

519

0.94

0.13

3.9

3.1

86.54

138.70

au/ml

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

117

0.85

0.13

1.0

1.1

70.40

93.81

titre

—

117

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

590

0.95

0.13

1.2

1000.00

995.58

titre

0.01

113

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

262

0.91

0.13

1.3

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

328

3207

1.02

0.12

1.1

4.97

5.68

u/ml

0.39

191

1853

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

656

1.05

0.12

1.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

238

1.09

0.12

1.6

1.8

3.28

2.23

ug/l

0.36

132

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

374

3663

1.02

0.12

1.1

1.53

2.43

u/ml

1.00

219

2053

(40758292) HTLV I+II Ab panel - Serum

261

0.92

0.12

1.1

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

689

0.95

0.11

7.9

7.2

9.63

83.87

ug/l

1.47

463

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

103

993

1.03

0.11

4.2

3.9

—

(3016330) Potassium [Moles/time] in 24 hour Urine

153

1.11

0.10

1.2

—

91.97

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

243

2472

0.98

0.10

1.4

4.12

3.84

ug/l

0.16

220

2245

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.13

0.10

1.6

1.2

—

(3001556) Androgen free Index in Serum or Plasma

173

1.10

0.10

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

485

1.05

0.09

1.2

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.08

0.09

1.2

163.40

284.94

nmol/l

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

634

0.96

0.09

1.1

1.2

9.07

9.79

mm/h

0.28

634

(40768795) Lymph node Pathology biopsy report

119

1156

1.03

0.08

1.2

—

(40757373) Influenza virus identified in Isolate

195

0.92

0.08

1.6

1.5

—

(3000285) Sodium [Moles/volume] in Blood

195

0.92

0.08

1.3

1.2

135.40

138.54

mmol/l

—

155

(3038177) Helicobacter pylori Ab [Presence] in Serum

220

2155

1.02

0.08

1.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

571

0.96

0.08

4.7

4.1

8.22

8.82

mg/l

0.29

459

(3041918) Cholesterol [Moles/volume] in Pleural fluid

194

1.08

0.08

1.0

1.2

1.84

1.65

mmol/l

0.34

127

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.82

0.08

1.0

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

304

3075

0.99

0.08

1.1

2.21

2.29

u/ml

0.06

173

1698

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.82

0.07

1.8

1.4

286.12

534.09

nmol/l

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.81

0.07

1.2

3.7

—

0.00

estimate

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

242

2450

0.98

0.07

1.1

6.67

6.05

u/ml

0.11

131

1182

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.06

0.07

4.3

3.0

—

(40768441) Liver Pathology biopsy report

933

1.03

0.07

1.6

1.5

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.85

0.07

1.0

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

108

1.11

0.07

1.2

—

(4038314) Semen analysis, post vasectomy

0.88

0.06

1.3

1.2

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

345

0.95

0.06

1.4

65.26

64.96

0.02

283

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

173

1754

0.98

0.06

1.4

7.06

7.00

mmol/l

0.12

163

1571

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

128

1.09

0.06

1.4

1.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

107

1088

0.98

0.05

1.1

23.36

17.55

u/ml

0.42

421

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

110

0.91

0.05

1.4

2.2

0.60

0.70

u/field

—

110

(3020491) Glucose [Moles/volume] in Blood

879

1.02

0.05

1.4

1.9

6.83

6.35

mmol/l

0.72

663

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

120

1217

0.98

0.05

1.2

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

211

0.95

0.05

1.6

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

684

0.98

0.04

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1060

10612

1.00

0.04

3.6

4.3

21.90

26.88

ug/l

0.12

839

8476

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

703

0.98

0.04

1.8

1.9

1.62

2.74

u/ml

0.53

218

(3004446) Plasmodium sp identified in Blood by Light microscopy

130

1.07

0.04

2.4

2.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1987

19858

1.00

0.03

2.5

2.3

—

(4133840) Spirometry

320

0.97

0.03

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

179

0.95

0.03

1.3

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

388

3846

1.01

0.03

3.0

3.6

537.86

1924.69

u/ml

1.05

334

3317

(3035320) C reactive protein [Mass/volume] in Body fluid

991

0.99

0.03

2.5

2.7

30.99

27.04

mg/l

0.41

700

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

188

0.95

0.02

1.1

1.0

0.03

0.12

u/ml

—

121

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

103

1038

0.99

0.02

1.3

1.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

257

0.97

0.01

1.1

1.4

1.20

1.17

mmol/l

0.85

257

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

287

0.97

0.01

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

586

0.99

0.01

5.2

6.5

67.00

6781.33

u/ml

—

105

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

116

0.95

0.01

1.1

1.0

0.04

0.22

u/ml

1.93

108

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

286

2845

1.00

0.00

1.5

90.57

137.43

pmol/l

1.77

279

2768

(3025130) Human papilloma virus identified in Specimen

221

2210

1.00

0.00

1.9

1.8

—

(3024263) Appearance of Synovial fluid

554

0.99

0.00

1.6

1.7

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

139

1.00

0.00

1.0

1.1

1.13

1.24

mom

0.25

139

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

178

1.01

0.00

1.3

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

365

1.01

0.00

1.4

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

242

0.99

0.00

1.5

1.4

25.43

25.67

g/l

0.02

182

(3002079) Sodium [Moles/time] in 24 hour Urine

576

1.00

0.00

1.1

1.3

149.31

160.36

mmol/24h

0.44

576

(3008401) Mugwort IgE Ab [Units/volume] in Serum

311

3098

1.00

0.00

1.1

0.95

1.17

u/ml

0.28

152

1528

(1617658) Protocol used for examination of sentinel lymph nodes

826

1.00

0.00

1.0

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

195

1.02

0.00

1.0

92.89

76.24

ug/l

0.69

161

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

156

1.02

0.00

1.4

6.00

10.38

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

278

1.00

0.00

1.0

1.1

—

34.00

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

289

1.00

0.00

1.3

1.4

12.77

13.36

g/l

0.13

218

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

490

4881

1.00

0.00

2.1

1.9

—

(3034426) Prothrombin time (PT)

420

1.00

0.00

1.2

28.40

28.13

0.14

420

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

575

1.01

0.00

1.1

5.22

10.18

u/ml

0.84

111

(3004541) Aldosterone [Moles/volume] in Urine

0.00

0.0

1.0

—

44.57

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

0.0

1.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

4.2

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.6

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

-0.00

0.0

1.6

—

21.81

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

-0.00

0.0

1.0

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

13.33

—

(44786798) Granulocytes/Leukocytes in Peritoneal dialysis fluid

0.00

-0.00

0.0

2.5

—

(3009179) Lactate [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.0

—

1.82

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

(3001729) Color of Synovial fluid

0.94

-0.00

1.6

1.5

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.98

-0.00

1.0

1.1

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.3

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

1.13

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.00

-0.00

1.2

1.6

45.78

44.51

umol/l

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: H7_STRABISMUS – Strabismus

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Strabismus

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Strabismus (H7_STRABISMUS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints